rfhg_104430.1

Basic information about the TSS

---

TSS ID: rfhg_104430.1 Species: human Chr: chr8		Start: 22566017 End: 22566030 Strand: +
Source datasets	PRJNA4843412|DRA013844
Protocol	NETCAGE|CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4070772,EH38E2616495)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000522721.1:-16 GeneID: 10174 HGNC/MGI_ID: HGNC:30907 UniProt_ID: E5RIA0 Nearer transcript ids and distances: ENST00000521554.4:-248 NM_001018003.3:-288 BC010146:-315 ENST00000523965.5:-339 AF064807:-339 CU679639:391 KJ892946:391 view more...

Gene_name: sorbin and SH3 domain containing 3 Gene_symbol: SORBS3 Gene_synonyms: SCAM-1 SH3D4 vinexin Gene_source: HGNC:30907

TATA-Box annotation

---

Distance to TSS:	294
Nearest PromoterID:	NM_001018003
Entrez ID:	10174
Nearest Unigene:	Hs.528572
Nearest Refseq:	NM_005775
Nearest Ensembl:	ENSG00000120896
Gene Name:	sorbin and SH3 domain containing 3
Gene Alias:	SCAM-1|SCAM1|SH3D4
Gene Type:	protein-coding
CpG%:	0.076923
GC%:	0.714286
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SORBS3 p2@SORBS3 p3@SORBS3 p4@SORBS3 p5@SORBS3 p6@SORBS3 p7@SORBS3 p8@SORBS3 p9@SORBS3 p10@SORBS3
Sample		p1@SORBS3	p2@SORBS3	p3@SORBS3	p4@SORBS3	p5@SORBS3	p6@SORBS3	p7@SORBS3	p8@SORBS3	p9@SORBS3	p10@SORBS3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.58	4.87	0.00	2.53	5.06	0.00	0.97	0.00	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.41	4.65	0.00	4.05	7.08	0.00	1.21	0.00	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	32.60	3.67	0.00	3.28	5.98	0.19	1.16	0.00	0.77	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	27.44	3.74	0.00	2.49	4.57	0.21	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.92	2.25	0.00	2.70	4.72	0.45	0.67	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.07	2.33	0.00	2.33	4.46	0.19	1.36	0.00	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.68	2.83	0.22	4.58	9.37	1.09	2.40	0.00	1.09	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.28	3.39	0.00	3.15	8.24	0.48	0.00	0.00	0.97	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	40.39	5.77	0.00	4.92	8.33	0.85	1.71	0.00	1.07	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	28.98	4.64	0.00	2.90	4.06	0.00	1.74	0.00	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	22.64	0.40	0.00	1.62	5.26	0.40	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	26.83	0.81	0.00	1.22	3.25	0.00	0.41	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.98	3.87	26.60	1.29	0.97	0.32	0.81	1.13	0.64	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.22	4.81	16.24	1.20	0.75	0.45	1.20	1.35	1.05	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	30.08	2.85	25.47	1.32	0.44	0.88	0.88	1.32	1.10	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	37.22	2.26	21.63	1.51	1.01	0.50	0.50	1.01	0.50	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	30.58	2.84	25.12	1.31	0.87	0.44	1.31	0.66	0.22	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.57	1.69	21.09	1.69	2.11	0.42	0.42	1.27	0.00	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.93	1.60	19.19	3.20	1.07	0.00	0.53	0.53	1.07	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	31.14	2.11	22.27	2.11	0.90	0.00	0.60	0.30	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.67	3.34	22.19	1.87	1.47	0.13	0.80	0.40	0.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.66	2.24	21.41	2.07	0.35	0.35	0.00	1.04	0.52	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	31.54	2.07	20.29	2.20	1.29	0.39	1.16	0.65	0.65	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.30	2.91	24.02	1.21	1.21	0.24	1.70	0.97	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.38	2.84	21.67	0.77	0.52	0.26	0.26	1.03	0.77	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.64	1.90	18.99	1.27	0.32	1.27	0.32	1.27	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.18	1.65	20.33	0.55	2.20	0.55	0.00	1.10	1.10	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	31.83	3.06	21.69	0.47	1.18	0.24	0.47	1.18	0.94	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.81	1.62	17.44	0.48	0.65	0.65	0.65	1.29	0.65	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.23	2.71	16.83	1.09	1.45	0.72	1.27	0.90	0.54	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	26.38	1.47	14.65	2.09	0.63	0.42	0.63	0.42	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	31.46	2.15	17.98	0.78	0.39	0.00	0.98	0.59	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.76	2.53	16.04	1.90	0.63	0.63	0.63	0.42	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.43	1.81	9.24	1.32	0.33	0.00	0.66	0.33	0.49	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.05	1.87	14.59	2.62	1.87	0.19	1.12	0.56	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	29.32	2.49	15.90	1.92	0.38	0.38	1.15	0.96	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.91	2.66	10.63	2.45	1.02	0.41	0.82	1.02	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	29.22	2.82	14.71	2.22	1.41	0.20	1.41	0.40	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.18	3.24	11.88	1.89	1.89	0.27	0.54	0.81	0.54	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	25.21	1.92	10.56	1.20	1.68	0.00	0.24	0.24	0.48	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.82	2.59	11.29	1.18	0.71	0.24	0.24	0.47	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.84	1.61	7.91	0.88	1.02	0.44	0.44	0.44	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	23.41	3.37	10.97	1.48	1.27	0.21	0.84	0.84	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	33.74	1.92	12.59	2.10	0.70	0.70	0.52	0.17	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	27.10	1.20	10.04	1.81	0.80	0.20	0.00	0.40	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	26.06	1.40	10.47	1.63	0.70	0.00	0.93	0.70	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.03	2.40	9.36	1.20	0.48	0.00	0.00	0.24	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.31	2.38	7.45	1.19	0.89	0.60	0.00	0.00	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.29	2.39	5.98	1.68	1.20	0.24	0.24	0.24	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.66	3.24	6.67	1.01	1.42	0.20	0.81	0.00	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.77	1.43	7.17	1.02	1.23	0.20	0.82	0.41	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	32.69	4.00	7.34	1.78	0.44	0.00	0.67	0.00	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.07	3.55	6.74	1.06	0.71	0.35	2.48	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.85	1.99	2.32	1.66	0.33	0.33	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	10.91	1.68	1.68	0.84	0.00	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	2.76	1.84	0.92	0.46	0.92	0.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	26.58	4.21	4.54	1.62	0.32	0.00	0.97	0.00	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.61	4.18	3.21	3.85	0.64	0.32	2.25	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	21.06	1.26	2.20	0.31	0.31	0.00	0.31	0.00	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.84	6.35	2.12	5.64	0.71	0.71	1.41	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	2.80	2.24	1.12	0.56	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	3.18	0.00	2.39	0.80	0.00	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	14.95	3.40	1.02	1.70	0.34	0.34	2.04	0.00	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	39.64	6.50	2.60	3.90	0.65	0.00	0.97	0.00	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	39.76	11.00	1.06	2.13	0.71	0.71	1.06	0.00	3.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	41.44	17.06	2.44	2.44	0.00	0.49	4.88	0.49	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	11.90	0.99	2.48	1.98	0.50	5.45	0.00	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	15.48	0.94	1.88	0.94	0.47	5.16	0.00	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	28.48	7.62	1.66	1.32	1.32	0.66	1.66	0.33	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	38.98	11.14	1.24	1.55	1.24	0.31	5.57	0.31	1.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	40.66	10.70	2.45	1.53	0.92	0.00	3.36	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	42.92	11.88	6.49	5.23	1.43	0.16	3.01	4.12	1.43	2.69
Adipocyte - breast, donor2	11327-117E4	36.26	8.82	6.74	4.65	1.60	0.80	1.12	4.33	1.93	1.93
Adipocyte - omental, donor1	11473-119C6	45.55	10.81	8.78	7.12	2.67	0.76	5.09	8.91	0.64	5.22
Adipocyte - omental, donor2	11474-119C7	49.33	20.93	2.99	5.23	0.00	0.75	2.24	3.74	4.48	2.99
Adipocyte - omental, donor3	11475-119C8	42.53	17.75	8.71	6.70	1.67	0.33	3.68	1.00	1.00	5.36
Adipocyte - perirenal, donor1	11476-119C9	38.92	11.48	0.64	5.10	3.19	0.00	1.28	2.55	3.19	3.19
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	12.09	0.00	4.40	2.20	0.00	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.10	5.87	2.71	3.61	0.45	0.90	2.71	0.90	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	38.23	5.04	3.48	1.74	0.52	0.00	1.74	1.91	1.22	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	33.05	4.50	10.37	5.48	0.59	0.00	1.76	5.87	0.98	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	22.65	2.06	8.75	1.80	1.29	0.00	0.51	0.77	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	24.53	2.79	13.66	3.62	1.12	0.00	0.84	5.85	1.12	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	37.03	2.94	14.70	1.76	0.59	1.18	0.00	8.23	1.76	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	23.89	1.69	9.81	2.98	0.64	0.08	0.40	2.90	0.48	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	17.75	1.61	36.15	2.26	0.00	0.00	0.32	3.87	0.00	2.26
Adipocyte differentiation, day08, donor3	13026-139E2	14.40	0.53	30.92	1.07	0.00	0.00	0.00	4.27	0.00	6.40
Adipocyte differentiation, day08, donor4	13029-139E5	17.25	2.23	11.69	1.11	0.00	0.00	0.00	6.12	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	25.79	2.08	8.32	2.50	0.83	0.00	0.00	2.08	0.83	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	12.81	0.50	20.34	0.50	0.25	0.00	0.25	1.51	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	13.74	0.98	18.65	1.64	0.65	0.33	0.00	7.85	0.65	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	12.79	1.22	5.18	0.91	0.61	0.00	0.00	4.57	0.00	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	49.50	17.24	0.00	8.62	5.97	6.19	1.77	0.00	2.43	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	85.34	22.23	0.00	13.98	6.81	12.55	4.66	0.00	6.10	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	41.93	9.58	0.00	3.59	1.20	1.20	5.99	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	71.24	20.33	0.00	6.66	3.78	1.26	3.78	0.00	3.78	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	71.96	15.06	0.00	3.35	3.35	0.00	5.02	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	79.71	16.44	0.00	6.37	3.49	1.85	4.52	0.00	4.11	0.00
Anulus Pulposus Cell, donor1	11248-116E6	75.52	11.21	5.72	6.41	3.55	2.17	3.09	4.23	1.37	2.52
Anulus Pulposus Cell, donor2	11463-119B5	79.11	13.47	8.82	7.59	3.43	2.20	2.94	5.14	0.73	5.39
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	30.55	4.49	1.80	1.35	0.90	0.45	0.90	0.00	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.13	4.78	0.00	3.04	0.87	1.30	1.74	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	4.28	0.00	4.28	0.00	0.00	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	28.10	6.58	3.89	4.18	4.18	0.30	0.60	0.00	1.79	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	10.12	0.00	1.26	2.53	0.00	0.00	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.80	4.62	0.00	2.64	0.66	1.32	1.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	32.49	9.42	1.30	1.95	1.62	0.32	3.25	0.00	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.16	9.22	0.00	3.40	2.43	0.49	2.43	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.13	4.16	0.00	0.00	0.59	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.23	7.53	0.38	4.90	1.88	0.00	0.75	0.00	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	28.30	5.81	0.00	2.90	1.45	0.00	1.45	0.00	2.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	6.27	0.00	0.00	2.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	31.14	6.75	0.00	3.29	1.81	0.49	1.65	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	27.30	6.82	0.00	4.09	0.00	0.00	0.00	0.00	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.54	8.44	0.00	1.96	1.81	0.00	2.26	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	33.75	6.43	0.54	1.61	1.61	1.61	2.14	0.00	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	29.10	7.75	0.00	3.02	2.65	0.38	1.89	0.00	1.89	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.13	6.41	0.00	3.47	2.41	0.27	1.60	0.00	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	4.88	0.00	3.90	1.95	0.00	0.00	0.00	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	29.52	8.13	0.00	1.16	1.16	0.33	1.49	0.00	1.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	1.20	0.00	0.00	1.20	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	7.08	3.54	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.53	7.03	0.00	3.26	2.57	0.34	1.37	0.00	1.89	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	31.07	7.28	0.49	2.43	1.94	0.00	0.49	0.00	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	34.53	7.97	0.00	2.28	1.90	1.14	0.76	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	32.71	4.85	0.00	1.21	1.21	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	30.21	6.27	0.00	2.28	0.57	1.71	2.28	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	31.21	7.48	0.00	1.92	2.78	0.64	1.50	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	28.13	3.87	0.00	3.10	1.55	1.03	0.26	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	26.28	6.57	0.47	1.88	0.94	0.94	1.41	0.00	2.35	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	31.19	7.72	0.00	2.25	2.57	0.96	1.29	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.11	3.57	0.00	2.85	1.43	0.71	2.85	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	29.25	6.43	0.00	2.92	2.34	0.58	3.51	0.00	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	31.31	7.83	0.00	2.41	1.51	0.30	2.71	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	4.75	0.00	5.94	2.38	1.19	1.19	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	32.04	8.65	0.00	1.02	2.54	0.00	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.05	7.39	0.00	2.55	1.02	0.76	1.78	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	21.60	5.72	0.00	0.00	0.64	0.64	1.27	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	41.00	8.63	0.00	3.02	2.59	0.86	1.29	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.15	5.93	0.00	3.81	2.33	0.64	2.33	0.21	1.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.85	3.48	0.00	2.03	1.45	0.58	0.58	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	38.73	11.34	0.00	0.00	0.94	0.94	1.89	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.11	5.76	0.00	3.05	2.37	1.19	2.54	0.00	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	12.68	0.00	4.23	4.23	2.11	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.30	8.15	0.00	2.36	3.86	1.07	1.50	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	26.47	2.41	0.00	3.01	2.41	0.00	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	5.83	0.00	2.92	0.73	0.00	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	36.78	5.98	0.00	2.07	3.22	0.46	1.84	0.00	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	7.65	0.00	2.55	7.65	0.00	2.55	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.59	5.85	0.00	1.02	1.27	0.25	1.27	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.55	8.67	0.21	3.10	2.27	0.21	1.86	0.00	2.06	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	27.23	6.12	0.00	2.75	2.45	0.61	0.92	0.00	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	28.20	4.78	0.00	1.43	0.00	0.96	1.43	0.00	3.35	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.25	5.99	0.00	2.00	2.22	0.67	2.22	0.00	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	3.05	0.00	1.53	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.69	3.88	0.00	1.11	0.00	0.55	1.66	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	24.36	5.30	0.00	2.91	1.59	0.53	1.32	0.00	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	26.17	2.54	0.36	2.18	1.09	0.00	1.45	0.00	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	112.13	11.67	0.37	12.77	19.77	2.33	0.98	0.25	2.58	0.00
Astrocyte - cerebellum, donor2	11580-120F5	121.01	17.80	0.34	13.69	17.12	2.05	2.40	0.17	4.96	0.86
Astrocyte - cerebellum, donor3	11661-122F5	93.34	4.40	0.00	6.29	9.65	0.63	0.84	0.00	1.89	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	57.87	5.23	0.00	8.71	6.27	0.70	0.00	0.70	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	61.31	7.77	0.00	10.52	7.44	1.62	1.78	0.65	1.46	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	66.82	9.10	0.15	13.28	6.26	0.89	1.49	1.19	1.49	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.46	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.25	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.34	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	3.14	0.26	4.18	0.00	0.00	0.00	0.00	0.00	0.26	0.00
Basophils, donor2	12242-129H1	9.74	0.00	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	6.91	0.73	10.73	0.15	0.15	0.44	0.29	0.15	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	29.97	5.39	0.00	1.08	0.65	3.45	0.86	0.00	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	69.95	28.80	0.46	3.66	2.29	4.11	4.11	0.00	6.40	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	7.17	0.00	21.52	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	36.40	10.04	0.00	3.14	1.88	10.67	0.63	0.00	3.14	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	63.01	14.97	0.21	9.57	3.33	9.36	2.70	0.00	4.37	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	68.63	10.13	0.23	5.07	1.38	11.51	1.15	0.00	1.38	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.01	6.12	0.00	1.44	0.54	2.34	1.80	0.00	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.52	0.00	0.00	0.00	0.00	1.03	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	17.91	1.28	0.32	2.24	0.00	0.32	1.92	0.00	1.60	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.94	0.00	10.71	1.13	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	10.39	0.19	15.96	0.56	0.19	0.00	0.00	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	5.71	0.44	15.15	0.88	0.22	0.22	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.57	0.00	212.57	0.57	0.28	0.00	0.00	1.98	0.00	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.76	0.00	188.78	0.00	0.76	0.00	0.00	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1.31	0.00	253.13	0.00	0.33	0.00	0.00	2.96	0.00	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	2.89	0.00	13.73	0.14	0.00	0.00	0.00	0.14	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	2.11	0.00	41.34	0.00	0.00	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	4.03	0.71	22.74	0.24	0.00	0.00	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.84	0.00	7.37	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.48	0.00	16.56	0.00	0.00	0.28	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.23	0.00	8.43	0.25	0.00	0.00	0.00	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.94	0.00	3.33	0.20	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.10	0.00	13.35	0.18	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.26	0.22	4.79	0.65	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.34	0.00	4.45	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.64	0.00	14.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	0.00	6.66	0.00	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	2.83	0.00	8.18	0.45	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.80	0.20	20.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.50	0.00	5.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1.83	0.23	5.03	0.00	0.00	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1.13	0.23	9.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.31	0.00	5.24	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.88	0.00	6.46	0.00	0.27	0.00	0.00	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.84	0.17	19.19	0.17	0.35	0.00	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.37	0.00	10.10	0.42	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.65	0.00	2.39	0.00	0.00	0.00	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	0.00	4.93	0.00	0.00	0.35	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	2.63	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.49	0.52	4.71	0.17	0.00	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	0.00	17.47	0.37	0.00	0.37	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.31	0.43	9.05	0.65	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	0.41	6.96	0.00	0.00	0.00	0.00	0.82	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.70	0.00	6.26	0.00	0.00	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.93	0.23	1.39	0.00	0.00	0.00	0.00	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.65	0.44	32.48	0.22	0.00	0.00	0.00	0.00	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	1.62	0.00	42.73	0.46	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	1.08	0.43	28.38	0.22	0.00	0.00	0.00	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	4.52	0.16	11.21	0.62	0.00	0.16	0.16	0.16	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	3.84	0.17	16.24	0.35	0.00	0.17	0.00	0.00	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	7.14	0.22	10.70	0.22	0.00	0.00	0.45	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	9.95	0.26	0.00	0.00	0.26	0.51	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.44	0.66	13.61	0.00	0.00	0.00	0.00	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.42	0.00	8.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.71	0.00	0.68	0.00	0.00	0.00	0.68	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	2.07	0.00	0.00	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	2.67	0.00	0.00	0.00	0.00	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1.07	0.00	0.54	0.00	0.00	0.00	0.00	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	0.00	2.35	0.00	0.00	0.00	0.00	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	0.00	4.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.73	0.73	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	1.01	0.00	2.02	0.00	0.00	0.00	0.00	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	12.05	0.00	2.01	1.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	4.49	0.00	1.69	0.00	0.00	0.56	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	11.27	1.13	1.50	1.88	0.00	0.38	0.38	1.50	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	7.44	0.68	0.45	0.90	0.00	0.00	0.00	1.35	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	45.70	0.36	3.21	0.71	0.00	0.71	0.00	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	47.15	0.61	3.06	0.61	0.61	1.84	0.00	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	44.83	1.22	0.61	0.30	0.00	1.22	0.91	0.00	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.79	0.51	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.49	0.67	0.00	0.22	0.00	0.22	0.00	0.00	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	5.75	0.57	0.29	0.00	0.29	0.29	0.29	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	21.81	0.47	0.47	0.00	0.47	1.90	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	21.07	1.40	0.00	0.00	0.00	0.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	0.00	13.18	3.30	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	5.78	0.00	0.00	0.29	0.00	0.14	0.43	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.08	0.51	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	4.35	0.32	0.32	0.32	0.32	0.00	0.00	0.00	0.16	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.03	0.00	0.45	0.00	0.90	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5.94	0.35	0.35	0.35	0.00	0.70	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	0.44	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.81	0.00	0.42	0.42	0.00	0.42	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.43	0.83	0.00	0.21	0.00	0.42	0.62	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.37	1.34	0.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.37	0.27	0.82	0.00	0.00	1.63	0.27	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	31.09	1.07	2.68	0.00	0.00	1.61	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	0.00	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	10.75	0.56	0.37	0.00	0.37	0.19	0.56	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	10.40	0.22	0.22	0.43	0.22	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	15.13	0.63	0.00	0.63	0.00	0.63	0.42	0.00	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	15.67	0.51	1.52	0.51	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	16.90	0.00	0.00	0.43	0.00	0.00	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.10	0.00	1.74	0.44	0.44	0.00	0.44	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.66	0.49	1.48	0.00	0.00	0.49	0.00	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	21.23	0.00	1.85	0.00	0.00	0.92	0.00	0.92	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	25.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	32.95	0.55	3.32	0.28	0.00	0.00	0.28	0.00	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	35.09	0.74	1.47	0.00	0.25	0.74	0.25	0.00	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	0.00	4.62	0.00	0.00	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	29.37	1.07	1.79	0.36	0.00	0.00	0.00	0.36	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	20.77	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	41.91	1.31	1.31	0.00	0.00	0.98	0.98	0.00	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	37.17	0.38	0.38	0.00	0.75	0.38	0.38	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	40.15	0.50	0.25	0.50	0.00	0.76	0.25	0.00	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.08	2.98	0.00	1.15	3.21	0.69	1.61	0.00	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.46	1.92	0.00	1.92	2.88	0.24	0.96	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.49	1.92	0.00	1.92	4.38	1.37	1.09	0.00	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	13.51	2.40	0.00	2.70	3.00	0.00	0.90	0.00	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.64	2.40	0.00	1.68	3.36	0.96	1.20	0.00	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.92	2.73	0.00	0.68	3.87	0.68	1.36	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.00	5.21	0.00	1.96	3.26	0.22	0.65	0.00	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.84	4.21	0.00	0.79	3.95	0.53	1.05	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.55	2.35	0.00	1.88	3.75	0.70	0.23	0.00	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	11.17	2.11	0.00	0.91	2.11	0.60	1.21	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.17	2.61	0.00	1.16	0.58	0.29	0.58	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	8.53	2.13	0.00	0.80	1.60	0.00	0.53	0.00	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.88	1.75	0.00	0.88	2.19	0.00	0.88	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	9.11	0.91	0.00	0.91	5.01	2.28	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	0.75	0.00	1.49	2.98	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.21	3.60	0.00	0.36	2.52	0.36	1.08	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.37	2.59	0.00	2.88	3.45	0.29	1.15	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.13	1.89	0.00	1.18	4.24	0.47	1.41	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.04	2.54	0.00	2.22	4.44	0.63	2.22	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.46	4.00	0.00	2.46	3.08	0.31	1.23	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.46	3.53	0.00	1.92	1.92	0.32	0.64	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	0.76	0.00	1.15	4.59	0.76	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	10.64	2.36	0.00	0.79	1.18	0.39	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	6.81	2.27	0.00	0.76	2.27	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	5.62	0.00	0.00	0.80	0.80	1.61	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3.50	0.00	0.00	0.00	1.40	1.40	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	8.01	1.00	0.00	0.00	0.00	1.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	40.21	10.97	10.97	3.66	10.97	0.00	1.83	3.66	0.00	5.48
Cardiac Myocyte, donor2	11605-120I3	57.31	14.33	0.49	6.92	5.93	0.49	4.45	0.00	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	57.98	21.36	1.05	7.47	8.00	1.37	5.89	0.84	2.63	0.53
Chondrocyte - de diff, donor1	11261-116G1	75.57	22.53	6.93	14.21	3.81	1.39	3.12	1.73	2.43	3.12
Chondrocyte - de diff, donor2	11338-117F6	59.70	16.70	5.33	4.98	4.62	3.91	3.20	3.55	1.42	2.49
Chondrocyte - de diff, donor3	11410-118E6	63.60	12.74	4.78	5.58	4.78	2.50	3.98	2.96	2.96	1.93
Chondrocyte - re diff, donor2	11339-117F7	34.02	7.16	2.69	0.90	1.79	0.90	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	59.45	9.30	6.07	5.66	2.02	2.83	2.83	2.43	1.62	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	52.79	5.85	0.46	4.13	13.54	1.26	0.69	0.00	1.03	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	34.42	6.41	0.43	5.56	10.90	0.21	1.50	0.00	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	50.18	6.19	0.27	5.75	10.80	1.95	1.42	0.18	1.77	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	43.83	3.58	19.62	4.13	25.86	3.21	1.28	5.32	1.65	4.59
Corneal Epithelial Cells, donor1	11526-119I5	53.14	14.05	0.00	3.95	2.20	5.49	2.20	0.00	3.29	0.00
Corneal Epithelial Cells, donor2	11606-120I4	34.13	4.55	0.00	2.28	0.00	2.28	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	39.88	7.92	0.00	4.09	1.53	4.86	1.53	0.00	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.65	1.32	47.88	0.00	0.00	0.50	0.50	0.33	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1.58	0.95	35.01	0.32	0.00	0.00	0.00	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	6.90	27.61	0.00	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.73	1.84	42.87	0.00	0.22	0.11	0.32	0.32	0.54	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.25	0.00	3.07	0.34	0.00	0.34	0.00	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	8.49	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.58	0.00	1.45	0.00	0.00	0.00	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	68.21	15.34	0.17	8.34	3.17	0.83	3.34	0.00	3.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	43.42	15.26	0.00	5.87	1.76	0.59	3.52	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	71.83	18.10	0.00	9.90	1.70	1.98	2.83	0.00	2.26	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	43.64	14.55	0.00	7.08	1.97	0.39	4.33	0.00	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	62.54	14.83	0.00	6.69	2.62	0.87	2.91	0.00	4.07	0.00
Endothelial Cells - Artery, donor2	11341-117F9	73.17	15.76	0.00	8.94	4.00	1.65	4.47	0.00	4.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	72.93	19.11	0.00	12.10	4.38	1.75	4.73	0.00	2.98	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.94	5.76	0.66	3.77	1.11	0.89	1.55	0.00	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.56	5.78	0.61	3.04	0.61	0.30	2.74	0.00	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	32.98	9.58	0.56	2.82	1.41	1.69	1.69	0.00	2.26	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	54.67	13.97	0.00	3.86	2.97	0.89	1.49	0.00	2.97	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	49.46	13.02	0.00	5.73	3.64	5.21	2.08	0.00	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	64.80	13.90	0.14	6.66	3.12	1.28	4.68	0.00	4.40	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	65.62	17.61	0.00	7.60	4.80	0.40	3.60	0.00	2.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	44.55	18.34	0.00	7.86	5.24	1.57	0.52	0.00	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	50.69	12.42	0.50	8.45	2.73	1.49	3.85	0.00	1.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	52.58	10.21	0.87	9.99	2.17	0.43	2.82	0.00	1.74	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	58.25	12.70	0.37	11.36	2.44	1.10	3.05	0.00	1.47	0.00
Endothelial Cells - Vein, donor1	11267-116G7	80.76	6.83	0.00	11.38	4.55	0.00	5.69	0.00	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	71.25	15.37	0.00	7.68	3.49	0.00	4.19	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	55.74	11.62	0.16	8.16	2.04	0.94	4.71	0.16	3.45	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	40.07	7.09	0.00	2.44	1.47	7.57	1.22	0.00	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	41.60	6.24	0.00	0.00	0.00	2.08	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	73.07	13.55	0.41	2.87	2.46	1.23	5.75	0.00	2.05	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	28.14	6.46	0.55	2.08	1.31	0.77	1.09	0.00	0.99	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	65.76	11.92	0.54	6.39	4.12	1.63	3.14	0.11	1.63	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	61.97	12.73	0.00	6.79	5.22	1.58	3.52	0.12	2.30	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	14.47	9.28	0.96	1.64	2.46	1.23	2.73	0.41	2.18	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	60.43	15.19	0.74	4.85	2.53	1.05	3.38	0.11	2.21	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.71	11.07	0.79	2.90	1.32	1.58	2.90	0.00	2.11	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	77.40	15.28	1.00	9.63	5.65	1.33	6.31	0.00	3.99	0.00
Fibroblast - Cardiac, donor1	11268-116G8	59.88	23.13	0.00	8.62	4.54	1.81	4.54	0.45	3.18	0.45
Fibroblast - Cardiac, donor2	11345-117G4	87.16	34.87	0.00	11.37	8.34	3.03	5.31	0.00	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	60.88	15.77	0.32	3.94	4.73	1.73	3.94	0.00	3.15	0.00
Fibroblast - Cardiac, donor4	11452-119A3	57.29	20.31	3.03	6.97	2.42	0.91	2.42	3.64	4.24	1.82
Fibroblast - Cardiac, donor5	11456-119A7	50.51	14.21	1.02	6.09	2.16	0.89	3.43	0.63	2.66	0.25
Fibroblast - Cardiac, donor6	11460-119B2	50.63	23.65	0.45	8.19	3.34	0.45	3.34	0.30	2.43	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	69.14	11.79	0.54	5.09	3.48	0.27	1.21	0.13	2.41	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	42.71	2.16	0.43	3.02	3.45	0.00	1.29	0.43	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	55.66	14.65	0.00	8.79	1.46	1.46	4.39	0.00	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	112.09	15.45	1.38	11.30	5.54	1.61	3.92	0.46	1.38	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	119.74	20.01	37.14	8.99	2.37	0.51	6.44	13.06	2.54	8.14
Fibroblast - Dermal, donor1	11269-116G9	24.89	7.98	3.52	3.29	1.41	0.23	1.17	0.94	2.82	0.47
Fibroblast - Dermal, donor2	11346-117G5	47.64	16.98	1.42	5.66	3.30	0.47	2.83	0.94	2.83	0.94
Fibroblast - Dermal, donor3	11418-118F5	36.02	17.41	3.87	2.66	1.33	0.73	3.26	0.24	2.18	0.24
Fibroblast - Dermal, donor4	11450-119A1	49.74	11.76	0.11	5.88	1.58	1.24	1.24	0.11	2.03	0.34
Fibroblast - Dermal, donor5	11454-119A5	65.59	11.17	0.52	7.68	2.44	0.52	1.57	0.70	2.97	0.52
Fibroblast - Dermal, donor6	11458-119A9	60.91	16.24	0.00	9.42	2.92	0.97	2.60	0.32	2.60	0.65
Fibroblast - Gingival, donor1	11237-116D4	40.60	15.20	7.91	4.37	1.87	1.46	4.16	2.92	1.67	2.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	75.98	15.98	5.24	7.07	3.67	2.36	4.19	0.79	3.93	0.79
Fibroblast - Gingival, donor2	11318-117D4	63.92	15.68	1.45	8.96	2.90	1.32	5.14	0.53	2.37	0.13
Fibroblast - Gingival, donor3	11394-118C8	76.96	15.18	22.24	8.12	1.16	0.87	6.28	16.44	2.22	12.47
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	45.71	9.35	14.54	5.19	1.04	0.00	4.16	4.16	0.00	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	43.17	8.46	9.34	3.88	1.59	0.53	2.82	6.70	1.59	4.05
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	84.34	18.24	0.94	11.38	7.79	1.71	3.90	2.34	2.49	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	64.37	15.82	0.68	8.25	4.46	1.89	3.65	0.68	1.49	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	186.67	30.35	1.41	18.70	9.53	4.23	8.82	0.00	6.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	66.83	16.23	4.53	10.82	3.66	1.46	4.97	1.90	1.61	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	72.95	14.45	2.05	8.45	4.23	1.50	2.86	0.41	1.91	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	66.47	12.07	0.44	12.40	3.73	0.99	2.08	0.11	1.65	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	74.54	10.71	7.48	6.90	1.76	0.29	5.58	6.90	1.32	4.99
Fibroblast - Lung, donor1	11270-116H1	87.00	27.19	0.00	4.08	2.72	0.00	12.23	0.00	6.80	0.00
Fibroblast - Lung, donor2	11347-117G6	62.67	8.95	4.48	5.97	4.48	0.00	4.48	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	68.38	17.30	0.84	6.54	3.17	0.21	2.95	0.63	3.80	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	204.92	109.96	0.83	14.16	15.83	5.83	14.99	0.00	8.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	102.10	41.96	4.20	4.20	1.40	0.00	9.79	0.00	5.59	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	87.32	28.83	0.84	8.68	5.04	1.68	5.32	0.00	4.20	0.28
Fibroblast - Mammary, donor1	11540-120B1	138.84	52.37	0.41	18.27	8.53	3.25	8.53	0.41	9.74	0.00
Fibroblast - Mammary, donor2	11620-122A9	99.86	43.94	0.00	15.98	7.99	3.99	3.99	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	113.17	29.78	0.00	5.96	5.96	0.00	17.87	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	49.46	14.94	1.55	6.98	2.72	0.97	2.91	0.58	2.72	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	90.86	19.57	0.61	14.56	4.25	3.19	4.70	0.91	3.19	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	67.01	26.31	2.14	9.49	3.98	0.61	6.12	0.31	6.12	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	71.36	15.65	2.29	5.34	6.11	1.91	2.29	0.38	2.67	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.66	11.88	1.89	4.05	1.35	0.27	3.24	1.35	2.43	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.43	5.91	9.63	4.29	1.39	0.12	2.55	7.07	1.28	3.13
Fibroblast - Pulmonary Artery, donor1	11250-116E8	38.02	11.38	0.00	6.74	3.09	0.99	3.43	0.00	2.54	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	116.43	64.82	4.06	18.90	18.08	2.03	13.41	0.61	7.31	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	80.18	18.71	0.67	10.02	4.68	0.00	10.69	2.00	4.01	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	73.14	14.63	3.95	5.93	1.98	0.79	5.14	3.16	3.56	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	33.34	17.86	0.20	4.76	5.95	1.19	2.78	0.20	2.78	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	51.86	15.10	1.42	4.09	2.49	0.53	5.86	0.53	2.49	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.95	13.60	0.59	4.34	5.52	1.18	3.15	0.39	1.77	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	19.86	18.65	0.30	3.61	3.31	0.90	2.71	0.00	3.61	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	62.50	25.69	1.08	5.51	6.26	2.37	5.40	0.32	5.07	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.97	10.63	1.27	1.52	3.04	1.77	1.52	1.52	3.29	1.27
Fibroblast - skin normal, donor1	11553-120C5	49.88	13.78	0.82	5.25	5.25	1.31	4.27	0.66	3.12	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.65	13.63	0.00	3.21	2.61	1.20	3.01	0.60	3.21	0.00
Fibroblast - skin normal, donor2	11561-120D4	56.46	18.99	0.10	5.53	4.62	2.11	3.32	0.00	3.72	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	25.39	13.90	0.60	2.42	6.35	3.32	2.72	0.00	6.95	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	58.49	15.49	2.57	5.22	2.65	1.74	5.30	0.66	1.91	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	74.19	41.88	20.86	7.69	3.08	0.00	10.09	3.93	2.91	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	19.38	11.17	0.66	2.63	3.28	0.66	2.63	0.33	1.97	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	53.37	15.66	0.00	6.50	4.37	1.70	2.66	0.00	3.30	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	58.03	21.59	0.17	5.57	4.39	1.69	5.06	0.51	3.04	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	35.60	8.31	0.16	4.39	1.73	2.04	2.35	0.63	1.57	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.09	4.36	9.59	1.74	0.00	6.10	0.00	4.36	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	29.30	9.01	0.00	3.12	2.25	5.37	0.87	0.00	1.73	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.09	11.97	0.00	4.68	2.08	5.73	2.86	0.00	1.30	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	33.22	10.48	0.00	4.09	2.30	3.07	1.28	0.00	3.07	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	61.24	1.53	0.00	1.53	4.59	0.00	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.92	0.00	0.00	0.64	5.74	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	33.95	0.86	1.14	3.71	1.71	0.57	0.00	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	79.97	2.21	0.00	4.69	4.14	0.28	0.83	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	47.95	0.46	0.00	3.88	4.11	0.00	0.46	0.00	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.15	1.59	0.20	6.34	2.77	0.00	0.00	0.00	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	86.44	2.11	0.00	5.55	3.17	0.26	0.26	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	67.51	1.96	0.00	2.61	4.89	0.00	0.00	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	34.94	0.88	0.00	4.42	1.33	0.44	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	67.41	1.84	0.99	5.51	5.65	0.42	0.42	0.85	0.85	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.11	2.34	1.48	2.96	4.68	0.37	0.49	0.37	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	50.23	1.34	0.54	5.10	6.45	0.00	0.54	0.27	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	66.16	5.70	1.24	6.94	10.28	0.25	1.49	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	72.26	3.74	0.55	8.44	7.48	0.42	0.83	0.69	1.66	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	54.49	4.07	1.22	5.90	9.96	0.41	1.83	0.20	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	77.81	3.88	1.37	7.30	9.81	0.46	0.91	0.91	1.14	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	77.11	5.48	3.61	9.47	7.47	0.25	1.49	0.62	1.74	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	83.93	4.15	2.40	8.09	12.68	0.22	0.66	0.22	0.87	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	63.82	3.84	1.18	5.02	11.23	0.00	1.48	0.89	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	61.83	3.50	1.11	5.40	8.11	0.00	1.59	0.48	1.91	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	66.58	2.90	1.79	2.68	10.50	0.00	1.34	0.89	0.89	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	61.50	3.23	1.21	4.23	8.47	0.00	1.21	0.20	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	53.44	3.56	0.85	4.92	6.28	0.17	1.02	0.00	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	69.43	5.68	2.13	5.41	11.17	0.09	2.04	0.27	0.44	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	122.99	7.39	4.06	9.16	11.13	0.00	3.02	1.14	1.14	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	97.68	7.51	5.12	7.34	11.44	0.34	2.56	0.17	0.51	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	65.06	4.87	2.88	4.32	6.64	0.11	1.88	0.11	1.22	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.16	3.74	2.75	5.24	9.40	0.25	0.83	0.33	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.15	5.92	3.06	3.47	9.60	0.00	1.43	0.41	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	56.32	4.54	2.06	5.36	4.54	0.00	1.65	1.65	1.44	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	70.44	4.27	3.34	5.88	8.19	0.12	1.50	0.58	0.81	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	47.69	4.67	8.34	2.33	3.17	0.00	1.00	0.67	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	66.35	3.75	6.61	3.75	7.05	0.22	1.54	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	63.09	3.69	7.26	2.83	4.06	0.12	1.97	0.49	1.11	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	46.03	2.27	4.54	2.59	4.05	0.32	0.81	0.32	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	53.88	3.53	3.85	2.89	4.49	0.00	0.32	1.92	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.73	4.26	6.73	5.12	3.88	0.28	1.04	0.76	1.14	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.06	2.53	11.55	1.90	3.64	0.00	0.16	0.79	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	38.62	4.56	6.99	2.43	6.39	0.30	1.82	0.91	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.60	4.60	4.50	3.45	4.18	0.21	0.94	0.84	0.94	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	33.37	2.63	15.15	2.20	4.39	0.22	1.32	1.10	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.15	2.81	5.61	2.24	4.77	0.28	1.12	1.12	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	36.20	5.09	9.44	3.70	2.87	0.09	1.85	0.46	0.93	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.88	3.74	19.79	2.14	2.67	0.80	1.07	0.00	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	32.90	2.75	6.58	3.21	4.28	0.15	2.60	0.46	1.38	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.77	4.66	9.84	4.40	2.07	0.00	1.42	0.13	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.09	2.71	32.53	2.44	3.52	0.27	1.08	0.27	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.19	6.08	12.72	3.13	3.87	0.37	1.66	0.55	1.29	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	49.56	7.46	10.53	2.85	2.41	0.00	2.85	0.88	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	75.37	7.93	75.37	3.97	5.95	0.00	3.97	3.97	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.13	8.71	7.39	4.62	4.09	0.13	3.69	0.53	1.06	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.99	6.66	6.46	4.24	3.03	0.00	2.42	0.61	1.21	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	139.03	22.62	53.63	9.15	8.64	0.25	11.69	4.32	1.78	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	61.31	1.99	0.00	2.39	1.19	0.60	0.20	0.00	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	60.40	1.39	1.08	2.77	2.00	0.00	0.15	0.15	0.62	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	68.74	1.43	0.20	4.30	2.66	0.00	0.61	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	35.99	0.31	0.00	1.56	2.82	0.00	0.00	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.91	0.28	0.00	3.67	3.11	0.00	0.00	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	42.43	0.92	0.00	3.69	2.77	0.00	0.00	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	0.00	0.00	0.00	9.90	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	39.45	0.77	0.00	2.32	9.28	0.77	0.77	0.77	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	0.00	0.00	6.42	11.23	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	0.00	0.00	0.00	6.96	1.74	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	29.94	0.98	0.33	1.30	7.81	0.33	0.00	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	34.18	0.41	0.00	2.47	11.53	0.00	0.00	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	59.98	0.00	3.33	6.66	10.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	37.47	0.84	0.00	4.47	11.75	0.00	0.56	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	46.08	0.33	0.00	2.61	16.67	0.00	0.33	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	58.72	0.00	0.00	4.19	14.26	0.00	1.68	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	55.66	1.59	0.64	3.50	14.31	0.32	0.95	0.32	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	39.40	0.68	0.00	2.38	13.25	0.00	0.34	0.68	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	0.00	0.00	4.18	12.53	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	67.01	2.29	0.00	4.58	12.60	0.00	0.57	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.00	2.37	0.00	5.62	11.84	0.00	0.00	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	47.44	1.69	0.00	3.39	15.25	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	45.98	1.66	0.41	6.63	12.43	0.41	0.83	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	41.65	1.84	0.00	6.21	11.74	0.00	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	0.00	0.00	10.54	21.07	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	46.90	2.31	0.00	3.46	13.84	0.00	0.38	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.24	3.26	0.33	5.22	13.04	0.33	0.65	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.18	2.68	0.67	6.02	14.71	0.00	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	80.14	3.08	0.00	8.48	21.19	0.00	0.39	0.00	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	72.92	5.82	0.34	6.50	20.88	0.00	1.03	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	2.48	2.48	4.97	14.91	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	76.91	3.77	0.47	4.72	12.27	0.47	0.00	0.00	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	76.04	4.22	0.00	7.85	18.71	0.00	1.81	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	73.76	2.54	0.00	6.10	17.29	0.00	2.54	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	63.81	3.99	0.00	3.19	13.56	0.00	0.80	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	73.02	4.93	0.00	6.41	23.19	0.00	0.49	0.00	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	4.72	0.00	3.54	16.53	0.00	0.00	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	69.43	1.75	0.00	5.83	12.25	0.00	1.17	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	84.27	5.27	0.00	8.34	17.99	0.00	1.76	0.88	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	54.25	2.54	0.00	3.39	13.56	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	3.58	0.00	5.37	17.31	0.00	0.60	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	35.91	2.91	0.00	4.37	7.28	0.00	1.46	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	41.09	9.13	1.14	1.14	2.28	0.00	1.14	0.00	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	59.46	9.15	1.66	7.07	4.57	1.25	0.83	0.42	2.91	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	116.94	22.49	0.00	11.24	7.87	1.12	4.50	0.00	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.43	20.93	17.13	4.12	3.49	0.32	10.78	5.71	4.44	5.71
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	35.09	14.62	16.71	2.92	0.42	0.00	9.61	4.18	1.25	9.19
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.00	1.51	0.00	4.87	1.86	5.57	0.12	0.00	0.70	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	24.48	2.36	0.17	5.06	2.19	6.25	0.17	0.00	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.29	2.28	0.00	3.64	1.82	4.55	0.68	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	24.70	3.28	0.00	6.56	1.97	5.68	0.33	0.00	0.87	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	25.14	2.79	0.00	5.37	1.72	6.88	0.00	0.00	1.29	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.22	2.58	0.00	4.09	2.37	5.38	0.65	0.00	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.91	2.49	0.00	5.73	1.37	6.48	0.37	0.00	1.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.21	1.72	0.00	4.29	1.89	5.32	0.34	0.00	0.69	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.62	3.20	0.00	5.13	1.28	4.81	0.32	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	90.10	11.19	1.12	10.07	1.68	1.68	3.92	0.00	6.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	85.26	19.04	0.87	13.85	8.66	1.73	6.06	0.00	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	7.93	0.00	5.29	2.64	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	77.60	28.22	0.71	12.70	16.93	1.76	6.35	0.00	6.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	85.00	29.06	2.91	18.89	10.90	0.73	7.99	0.73	2.18	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	54.90	12.06	0.00	9.79	4.02	1.05	3.67	0.00	2.27	0.00
Hepatocyte, donor1	11523-119I2	12.11	1.21	2.42	1.21	133.17	8.47	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	4.31	0.00	2.15	0.00	49.56	3.23	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	15.95	3.68	9.82	1.84	61.97	0.61	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.65	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	33.91	3.85	1.05	5.77	13.63	1.92	0.52	0.00	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	44.18	9.19	0.55	5.63	8.37	0.96	1.37	0.00	1.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	0.00	0.00	1.38	1.38	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	0.00	0.00	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	0.00	0.00	0.00	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	10.59	0.00	0.00	1.32	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	0.00	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.30	0.63	0.00	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	0.00	0.00	0.00	0.65	0.00	0.65	0.00	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	1.61	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	0.00	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	0.84	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	0.47	0.00	0.94	0.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	1.08	0.00	1.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.01	1.91	0.00	1.28	0.64	0.00	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	8.57	0.00	0.00	0.71	0.00	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.94	0.62	0.00	0.62	1.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.26	0.70	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	0.00	0.00	0.00	0.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	16.00	0.00	0.00	1.07	0.00	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	0.00	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	0.00	0.00	2.76	0.00	0.00	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	53.28	11.42	0.00	3.84	1.22	6.94	1.39	0.00	1.31	0.00
Keratinocyte - epidermal, donor2	11349-117G8	69.10	10.54	0.00	6.44	2.34	8.78	1.17	0.00	2.93	0.00
Keratinocyte - epidermal, donor3	11421-118F8	55.28	10.79	0.00	8.52	1.42	6.53	2.27	0.00	2.93	0.00
Keratinocyte - oral, donor1	11251-116E9	75.72	11.58	0.00	3.86	2.84	4.88	2.95	0.00	2.72	0.00
Keratocytes, donor1	11527-119I6	116.56	8.25	4.81	7.22	2.41	1.03	3.09	2.06	1.03	1.03
Keratocytes, donor2	11607-120I5	63.28	25.78	1.17	7.03	2.34	2.34	5.86	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	58.69	5.14	4.94	3.56	0.59	0.20	2.37	3.56	0.59	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	0.00	0.00	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	46.39	10.79	0.00	10.79	9.71	1.08	4.31	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	67.24	5.65	1.61	4.50	10.50	1.04	0.58	1.27	1.15	0.46
Lens Epithelial Cells, donor3	11690-122I7	29.97	8.78	0.00	3.63	4.34	1.01	2.62	0.00	2.02	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	39.72	10.43	0.24	4.86	2.96	2.61	2.25	0.00	2.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	36.56	5.30	0.28	2.79	1.95	1.12	0.84	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	28.18	5.98	0.16	4.56	2.05	1.73	1.42	0.00	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.57	8.60	0.00	2.15	1.08	0.54	0.54	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	34.98	6.30	0.00	5.04	2.21	1.58	1.58	0.00	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.96	6.25	0.11	3.67	1.94	1.51	0.97	0.00	1.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	4.51	0.41	4.92	1.64	1.64	2.87	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	37.92	6.07	0.25	3.54	2.28	1.52	1.77	0.00	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	39.55	6.76	0.14	4.64	1.55	2.82	1.27	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.06	6.33	0.00	2.77	3.16	0.40	1.58	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	34.32	4.85	0.00	3.88	1.94	2.33	1.36	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	35.92	5.37	0.19	4.07	2.96	1.67	1.85	0.00	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	24.74	6.97	0.00	4.53	1.74	2.44	1.39	0.00	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	37.21	5.25	0.24	4.77	1.19	2.39	1.67	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	35.57	6.32	0.00	3.57	2.20	3.30	1.79	0.00	1.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	30.18	7.39	0.00	2.77	1.54	3.08	0.92	0.00	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.17	4.36	0.00	3.12	2.49	2.49	1.87	0.00	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	42.09	7.87	0.00	3.84	2.74	2.74	1.65	0.00	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.59	5.27	0.00	2.30	2.30	1.32	0.00	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	40.71	2.64	0.29	2.64	2.34	4.39	1.46	0.00	1.17	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	41.82	5.97	0.00	2.24	2.24	2.49	1.99	0.00	1.49	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.98	8.24	0.00	3.88	0.48	0.00	3.88	0.00	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.93	7.81	0.00	2.42	1.89	1.35	1.08	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.18	4.84	0.15	4.54	2.57	2.72	1.36	0.00	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.85	4.67	0.00	3.63	2.59	0.52	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.90	5.86	0.00	4.19	3.14	1.88	1.47	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.49	8.12	0.45	4.06	2.26	2.41	2.26	0.00	1.80	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	6.19	0.00	5.50	3.44	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.04	4.70	0.19	3.39	2.45	1.51	0.94	0.19	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	37.75	7.21	0.11	3.71	3.07	3.29	2.44	0.00	1.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.98	10.18	0.00	2.91	1.94	1.45	2.91	0.00	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.79	2.65	0.00	2.32	1.32	0.99	1.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	43.11	7.68	0.25	4.83	2.35	2.23	1.86	0.00	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	30.36	8.51	0.00	2.96	0.00	1.48	1.48	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.43	3.71	0.00	2.47	1.48	1.24	0.74	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	33.82	6.32	0.14	2.89	1.51	1.79	1.65	0.00	1.51	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	34.09	5.15	0.00	3.22	2.25	1.61	2.57	0.00	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.82	5.17	0.30	2.43	0.91	3.04	0.91	0.00	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.97	6.02	0.28	4.48	2.52	3.36	0.70	0.00	1.12	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.51	4.98	0.00	3.56	1.07	0.36	2.49	0.00	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	31.03	1.94	0.00	1.94	2.42	2.91	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	40.77	7.62	0.16	5.45	2.33	2.65	2.33	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.65	5.73	0.00	2.15	1.07	2.15	3.22	0.00	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.28	3.27	0.65	3.59	3.92	0.98	1.31	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	33.90	6.36	0.24	3.53	2.59	3.53	1.41	0.00	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.25	10.27	0.00	5.07	2.85	2.97	2.23	0.37	1.49	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	32.02	4.61	0.26	2.31	3.07	1.54	0.51	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	33.42	4.77	0.00	4.48	1.19	1.19	1.49	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	0.00	0.00	0.00	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	1.53	0.00	3.07	0.77	0.00	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	10.39	2.97	0.74	0.00	1.48	0.74	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.73	1.27	0.00	0.00	0.85	0.85	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	1.41	0.00	0.70	0.00	3.52	0.70	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	2.80	0.00	0.93	0.93	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	2.06	0.00	0.00	2.06	1.55	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	1.19	0.00	0.00	2.38	1.19	1.19	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.18	1.13	0.00	0.45	0.23	1.81	0.00	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.14	1.16	0.00	0.00	0.58	0.00	0.00	0.00	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	0.90	0.00	0.00	0.00	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	13.41	2.85	0.00	0.68	0.27	1.63	0.41	0.00	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	1.03	0.00	1.03	0.51	1.54	1.03	0.00	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.23	0.71	0.00	0.00	1.41	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	5.33	0.67	0.00	0.67	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.23	1.53	0.00	1.02	0.00	2.04	1.53	0.00	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.74	2.40	0.00	0.00	1.33	0.53	0.27	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	8.12	1.51	0.00	0.19	0.94	2.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.20	1.23	0.00	0.00	3.07	1.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	0.82	0.00	0.82	0.82	0.82	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.95	1.04	0.00	0.00	0.62	0.62	0.21	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.89	0.28	0.00	0.00	0.84	1.12	0.28	0.00	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	0.00	0.00	1.03	0.00	3.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.55	2.32	0.00	0.29	0.58	1.16	0.29	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	5.98	0.60	0.00	0.30	0.90	2.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	3.32	0.00	0.55	0.55	1.66	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.08	1.06	0.00	0.00	1.77	1.06	0.71	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	6.64	2.58	0.00	1.48	1.11	1.11	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	1.15	0.00	0.00	0.00	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.28	1.15	0.00	0.00	0.77	0.77	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.32	0.57	0.00	0.57	1.13	3.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	2.46	0.00	0.82	0.00	1.64	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.04	0.90	0.00	0.45	1.36	0.45	0.90	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	0.72	0.72	0.00	2.15	0.72	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	1.49	0.00	2.99	0.75	3.73	0.75	0.00	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.24	4.46	0.00	0.37	1.86	1.86	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.46	1.29	0.00	0.00	0.00	1.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	6.85	1.71	0.00	0.86	0.86	0.86	1.71	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.99	2.33	0.00	0.33	1.67	0.33	0.67	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	0.60	0.00	0.00	0.60	0.60	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	5.69	3.55	0.00	2.13	0.00	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.97	1.72	0.00	0.69	0.69	1.72	0.00	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	3.22	0.00	1.07	0.00	3.22	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	3.37	0.00	0.00	0.67	1.35	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.30	2.59	0.00	0.00	0.74	1.85	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	2.33	0.00	1.16	0.00	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	0.00	0.00	0.00	1.06	2.12	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.41	2.00	0.00	0.80	2.00	3.60	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.09	0.73	0.00	0.00	0.73	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.80	3.83	0.00	0.00	3.07	2.30	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.83	1.48	0.00	0.49	0.00	1.48	0.49	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.07	3.52	0.00	0.50	1.01	0.50	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	11.72	0.45	0.45	0.45	0.90	1.35	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.24	1.34	0.00	0.89	0.89	1.78	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.90	1.17	0.39	0.00	0.78	1.56	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	1.98	0.00	0.00	1.32	1.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.26	1.04	0.00	0.00	1.04	0.52	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	13.56	3.06	0.00	0.88	0.44	0.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	2.24	0.00	1.12	1.12	1.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.27	2.65	0.00	0.88	0.88	1.32	0.44	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.03	3.09	0.00	0.77	2.31	2.70	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.09	2.03	0.00	0.00	1.52	1.52	1.01	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.57	1.92	0.00	0.96	1.44	1.44	0.48	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	12.32	2.78	0.00	0.80	1.19	2.78	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4.86	1.22	0.00	1.22	1.82	1.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.23	2.77	0.00	0.00	1.38	0.69	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.74	0.76	0.00	0.38	2.28	2.28	1.52	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.26	3.10	0.00	0.00	0.52	2.07	0.52	0.00	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	2.42	0.00	0.00	0.60	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.14	2.85	0.00	0.32	0.63	1.58	0.95	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.40	1.60	0.00	0.00	1.60	0.00	0.53	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	7.47	4.02	0.00	0.57	1.15	1.15	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	3.60	0.00	1.03	2.06	2.57	1.03	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	3.54	0.00	1.41	3.54	0.71	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	5.11	0.57	1.13	1.13	1.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.65	2.08	0.00	0.00	1.25	1.66	1.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	3.13	0.00	1.57	1.57	0.78	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.53	1.67	0.00	0.84	0.84	1.67	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	13.47	3.25	0.00	0.46	1.86	1.39	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	0.67	0.00	0.67	2.68	1.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	10.16	2.67	0.00	1.07	0.53	3.74	0.53	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	12.93	1.62	0.00	0.00	2.02	2.02	0.40	0.00	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	0.92	0.00	0.00	0.92	2.75	0.00	0.00	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	6.22	6.22	0.00	2.67	0.00	3.56	0.00	0.00	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	3.99	0.00	0.57	0.00	1.71	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	3.07	0.00	0.00	3.83	1.53	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	3.28	0.00	0.00	1.09	1.09	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.36	5.35	0.45	1.78	1.78	3.12	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.92	4.68	0.00	1.04	1.56	2.86	1.30	0.00	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	2.65	0.00	1.33	3.98	2.65	0.66	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	8.31	0.00	0.00	0.00	6.24	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.00	0.00	99.37	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.00	0.00	50.83	0.00	0.00	0.00	0.00	0.73	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.13	0.00	87.17	0.13	0.00	0.00	0.00	0.92	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	5.31	0.00	3.19	1.59	2.12	0.53	0.00	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	40.72	8.56	0.00	3.96	2.85	4.28	1.43	0.00	1.27	0.00
Mallassez-derived cells, donor3	11930-125I4	34.33	9.03	0.00	4.17	2.36	5.70	0.42	0.00	2.36	0.00
Mammary Epithelial Cell, donor1	11273-116H4	41.55	5.48	0.00	2.59	2.19	10.96	0.70	0.00	1.59	0.00
Mammary Epithelial Cell, donor2	11350-117G9	34.75	7.24	0.29	3.76	2.61	9.56	1.16	0.00	1.74	0.00
Mammary Epithelial Cell, donor3	11422-118F9	68.59	14.72	0.00	9.73	1.75	7.73	1.75	0.00	4.74	0.00
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	2.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	1.62	0.11	11.79	0.00	0.22	0.00	0.00	0.11	0.22	0.00
Mast cell, donor2	11565-120D8	38.34	2.08	78.45	0.89	0.59	0.30	0.30	1.19	0.89	0.00
Mast cell, donor3	11566-120D9	61.91	6.30	59.43	2.25	0.45	1.13	1.13	0.23	1.80	0.68
Mast cell, donor4	11567-120E1	52.83	2.66	78.54	2.84	0.35	0.71	0.35	1.60	1.24	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	0.78	0.00	13.86	0.00	0.11	0.00	0.00	0.00	0.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	0.58	0.00	5.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	1.15	0.00	27.19	0.23	0.11	0.00	0.11	0.34	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	3.18	0.17	10.38	0.00	0.50	0.00	0.00	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	52.63	15.92	0.20	6.27	3.48	2.59	4.78	0.00	2.59	0.00
Melanocyte - dark, donor2	11582-120F7	40.15	14.19	0.00	6.58	4.15	1.73	5.19	0.00	2.42	0.35
Melanocyte - dark, donor3	11663-122F7	10.14	1.01	32.53	0.94	0.14	0.00	0.51	0.14	0.51	0.43
Melanocyte - light, donor1	11274-116H5	29.38	4.23	40.67	1.88	0.94	0.24	0.71	1.18	0.71	0.71
Melanocyte - light, donor2	11351-117H1	28.66	2.73	144.68	1.36	2.05	0.00	0.68	0.68	2.05	0.68
Melanocyte - light, donor3	11423-118G1	36.42	6.94	40.76	3.47	0.00	0.00	0.00	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	23.53	5.41	10.93	3.54	0.62	0.10	1.56	0.21	2.29	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	23.40	3.23	25.55	3.23	0.54	0.00	0.81	0.81	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	19.55	1.07	58.12	0.54	0.27	0.00	0.00	1.07	0.00	0.80
Meningeal Cells, donor1	11493-119E8	86.97	10.79	0.25	8.56	7.69	0.74	0.99	0.74	2.85	0.25
Meningeal Cells, donor2	11573-120E7	73.06	5.72	0.44	8.36	6.60	0.00	0.44	0.44	3.08	0.00
Meningeal Cells, donor3	11654-122E7	52.65	4.81	0.08	6.19	4.89	0.16	0.33	0.16	1.14	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	61.02	13.40	2.00	6.56	6.84	0.86	3.42	1.14	2.28	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.26	6.24	1.01	1.11	1.31	0.50	1.51	0.00	1.41	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	264.15	46.00	127.47	9.20	5.26	0.00	13.14	14.46	5.26	18.40
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	95.50	9.16	7.85	14.39	7.85	2.62	6.54	3.92	1.31	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	35.16	17.94	0.72	5.02	5.74	1.44	4.31	0.72	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	36.21	11.44	3.60	3.60	3.81	0.42	2.12	0.64	1.69	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.72	9.55	1.51	5.53	4.02	1.01	0.50	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	69.88	20.00	0.66	9.01	12.75	0.66	6.37	0.22	4.40	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	70.14	13.88	0.00	8.77	6.58	1.46	2.92	0.00	3.65	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	64.45	19.44	0.20	10.03	6.55	1.84	3.68	0.20	4.09	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	46.26	15.37	4.02	2.35	1.11	0.28	2.91	0.69	1.52	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	72.11	16.36	1.49	4.09	10.78	1.86	1.12	0.00	1.86	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	73.02	13.29	1.18	7.37	3.42	0.79	4.87	0.00	1.58	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	90.80	20.77	1.19	9.20	1.78	0.30	5.93	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	123.78	11.68	9.34	9.34	2.34	4.67	4.67	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	71.08	12.81	0.00	12.81	7.04	1.28	6.40	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.22	13.47	0.00	5.67	3.19	1.06	3.54	1.77	2.84	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	64.73	14.70	0.94	5.94	2.81	0.63	3.75	0.31	1.56	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	36.28	8.71	0.73	3.63	2.90	1.45	1.45	0.00	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	21.74	5.30	1.33	1.59	2.12	1.06	1.33	0.00	1.59	0.00
Mesothelial Cells, donor2	12156-128G5	21.02	2.00	2.00	1.00	2.50	1.00	1.50	0.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	31.65	4.99	0.43	3.18	2.82	2.10	1.30	0.07	2.02	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	1.35	170.14	0.00	0.00	0.00	0.00	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.00	0.00	131.26	0.00	0.49	0.25	0.00	0.74	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.00	0.29	72.44	0.29	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	155.57	0.00	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.00	0.00	86.48	0.00	0.00	0.00	0.00	0.62	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.41	0.21	57.25	0.00	0.62	0.00	0.21	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	108.85	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.00	0.25	90.34	0.00	0.75	0.00	0.00	2.75	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.93	0.47	96.35	0.00	0.00	0.00	0.00	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	194.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.20	0.00	81.49	0.00	0.41	0.00	0.20	0.61	0.00	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.79	0.79	63.35	0.00	0.00	0.00	0.00	1.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	179.58	0.00	0.00	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	0.00	81.41	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.14	0.38	52.43	0.00	0.00	0.00	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	88.17	0.00	0.00	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.21	0.00	68.12	0.00	0.21	0.00	0.21	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.00	71.82	0.00	0.00	0.00	0.92	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.00	0.30	80.18	0.00	0.00	0.00	0.00	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	53.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.25	0.00	59.71	0.00	0.25	0.00	0.00	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.24	0.24	41.35	0.00	0.24	0.00	0.48	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.00	40.91	0.00	0.00	0.00	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.00	0.46	36.15	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.42	0.42	38.49	0.00	0.00	0.21	0.21	0.84	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.00	0.00	31.59	0.00	0.00	0.00	0.00	0.41	0.20	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.00	0.21	46.98	0.00	0.00	0.00	0.00	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.89	0.67	38.23	0.00	1.11	0.22	0.22	0.67	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	51.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.00	0.00	27.60	0.00	0.00	0.00	0.00	0.88	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	0.00	43.09	0.51	0.51	0.00	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	43.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.00	0.27	31.26	0.00	0.27	0.00	0.00	1.63	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.00	0.59	28.23	0.00	0.29	0.00	0.29	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	21.81	0.00	0.00	0.00	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	0.00	15.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.00	0.00	24.01	0.00	0.40	0.00	0.00	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	35.65	0.00	1.37	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.00	0.50	19.52	0.00	0.00	0.00	0.50	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	28.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.44	21.90	0.44	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	1.10	32.01	0.00	0.00	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	0.00	28.18	0.00	0.00	0.00	0.00	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.00	0.50	17.85	0.00	0.25	0.00	0.00	1.49	0.00	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.00	27.84	0.00	0.00	0.00	0.00	2.09	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	44.20	0.00	0.00	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.00	25.30	0.00	0.00	0.00	0.00	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	1.75	32.38	0.00	0.00	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	0.00	55.75	0.36	0.36	0.00	0.00	3.20	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	0.00	29.74	0.28	0.00	0.00	0.28	0.84	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.42	0.83	32.00	0.42	0.42	0.00	0.42	0.42	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.58	0.00	52.45	0.00	0.00	0.58	0.00	1.17	0.00	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.30	0.30	43.14	0.00	0.90	0.00	0.00	2.41	0.00	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.42	1.67	33.39	0.42	0.00	0.00	0.00	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	57.75	0.00	0.00	0.00	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	0.00	36.94	0.00	0.00	0.00	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	1.14	45.53	0.00	0.00	0.00	0.00	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.00	0.28	43.53	0.00	0.00	0.00	0.00	2.21	0.00	1.38
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.00	0.26	33.43	0.00	0.00	0.00	0.00	2.07	0.00	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.86	0.00	41.61	0.00	0.00	0.00	0.00	1.29	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00	47.64	0.00	0.00	0.00	0.00	1.91	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.00	0.27	35.50	0.00	0.00	0.00	0.00	2.94	0.00	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.30	0.60	46.70	0.00	0.30	0.00	0.30	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.14	0.00	41.95	0.00	0.00	0.00	0.00	0.99	0.00	1.13
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.00	0.00	33.13	0.00	0.32	0.00	0.00	1.91	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.22	0.66	47.10	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	0.00	45.88	0.00	0.00	0.00	0.00	1.52	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.00	0.28	40.63	0.00	0.00	0.00	0.00	2.27	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.00	0.00	40.31	0.00	0.00	0.25	0.00	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.00	41.06	0.00	0.00	0.00	0.00	1.30	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.00	52.04	0.00	0.00	0.00	0.29	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.00	0.58	39.50	0.00	0.00	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	0.82	46.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	0.00	60.45	0.00	0.00	0.00	0.00	2.08	0.00	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	75.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	60.60	0.00	0.00	0.00	0.00	1.78	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.33	0.00	144.57	0.00	0.00	0.00	0.00	1.31	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	87.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	0.00	129.88	0.00	0.00	0.00	0.00	1.19	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	0.00	222.59	0.00	1.86	0.00	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.38	0.00	145.71	0.00	0.00	0.00	0.00	1.50	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	0.00	104.41	0.00	0.27	0.00	0.00	0.53	0.00	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	0.00	60.17	0.00	0.00	0.00	0.00	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	0.74	129.66	0.00	0.74	0.00	0.00	2.95	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	128.98	0.00	0.00	0.00	0.00	0.73	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	80.89	0.00	0.00	0.00	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.00	33.14	0.00	0.00	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	96.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	149.47	0.00	1.01	0.00	0.00	0.00	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.00	74.21	0.00	0.00	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	13.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	9.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	19.64	0.00	0.00	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	97.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	29.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	52.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	75.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	37.49	10.99	9.05	5.39	4.31	1.08	2.59	8.62	2.37	10.13
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.58	10.45	17.25	4.70	3.66	0.00	2.09	26.65	3.66	28.74
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	71.42	4.67	0.00	8.01	2.67	0.00	2.67	0.67	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	77.63	11.27	1.67	6.26	3.34	1.25	2.50	0.00	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	31.56	5.89	0.00	4.37	1.71	0.38	0.95	0.38	1.71	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	129.26	7.98	0.00	9.58	12.77	1.60	1.60	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	60.52	6.12	1.36	4.08	0.68	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	1.84	1.84	0.00	1.84	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	57.34	5.02	5.86	3.77	1.26	0.00	1.26	0.84	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	52.76	9.30	3.02	4.42	1.16	1.39	2.79	0.23	1.86	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	77.28	8.38	6.49	4.32	1.89	0.00	0.54	1.62	0.81	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	61.81	5.68	1.68	3.15	2.73	1.68	1.47	0.42	3.36	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	11.13	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	58.07	5.96	5.46	4.96	1.49	0.50	3.97	0.50	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	31.67	4.06	3.52	3.52	0.54	0.27	0.54	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	49.19	7.93	7.48	2.95	1.81	0.45	2.49	0.91	1.36	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	69.40	4.25	12.90	5.06	1.80	0.16	1.80	1.80	1.63	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.91	4.01	4.19	3.10	3.10	0.00	2.00	0.91	0.91	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	57.29	5.83	14.32	2.12	0.53	0.53	1.06	0.53	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	71.44	7.80	15.01	4.20	1.20	1.20	6.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.96	0.66	1.64	1.31	0.33	0.00	0.98	1.64	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	48.46	8.62	10.25	5.20	0.81	0.33	2.60	0.98	1.63	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	56.97	6.70	7.58	3.88	1.23	0.71	2.82	1.94	0.71	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	43.60	5.63	13.36	4.22	1.41	0.00	5.63	0.70	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	58.84	7.36	16.09	1.38	0.00	0.00	4.14	1.38	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	55.27	8.35	6.75	5.46	0.32	0.32	2.25	0.32	1.29	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.97	7.93	2.41	2.76	1.72	0.00	0.69	1.38	0.34	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	10.11	0.00	5.06	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	53.91	4.01	9.58	5.57	0.89	0.00	1.34	1.56	1.11	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	43.61	5.93	12.28	3.81	0.85	0.42	2.96	1.69	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	37.26	5.22	9.49	2.61	0.00	0.00	1.90	1.66	0.24	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	54.51	7.30	6.01	1.72	0.00	0.43	1.29	0.86	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	57.65	4.67	19.99	1.00	1.33	0.00	3.00	1.67	1.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	56.36	4.96	3.16	7.21	1.80	0.90	3.16	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	42.85	4.36	2.78	2.78	1.59	0.00	1.59	0.40	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	49.22	11.14	8.36	0.93	1.86	0.93	3.71	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.89	5.30	3.41	2.27	0.76	0.00	3.78	0.76	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	52.47	8.80	3.58	5.54	1.30	0.65	3.58	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	91.08	9.59	32.25	2.18	2.18	0.00	1.74	3.49	1.31	3.05
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	51.11	3.62	4.07	2.26	1.81	0.45	1.81	1.81	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	41.45	8.82	8.82	4.41	2.65	0.88	2.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	50.53	6.65	9.97	5.32	1.33	0.00	3.32	1.99	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	56.55	7.94	10.91	6.45	0.00	0.00	2.48	0.00	0.50	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	68.91	9.57	5.36	4.59	0.77	0.38	4.59	0.77	2.68	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.83	4.23	13.01	1.51	1.21	0.00	0.91	0.91	1.51	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.25	5.75	3.54	3.98	1.99	0.22	0.44	0.44	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	46.08	7.45	5.42	2.03	0.00	0.00	3.39	1.36	0.68	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	49.38	4.27	10.36	4.27	2.44	0.00	3.05	0.61	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	62.95	11.96	4.41	3.78	1.26	0.63	3.46	0.31	3.15	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	76.27	8.78	27.24	3.93	1.21	0.00	2.72	3.03	0.91	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	48.26	3.96	4.75	0.79	0.79	0.79	0.79	1.58	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	4.53	2.27	2.27	1.13	1.13	0.00	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.08	9.07	0.25	3.60	1.24	0.87	1.61	0.37	1.24	0.50
Myoblast, donor2	11322-117D8	42.39	15.53	3.64	8.06	4.03	1.73	2.11	0.77	2.49	1.15
Myoblast, donor3	11398-118D3	41.03	6.56	0.84	4.71	2.86	1.35	1.01	0.84	1.85	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	1.02	0.00	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	17.84	0.62	1.85	0.00	0.00	0.62	0.31	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	26.24	0.30	0.60	0.30	0.90	0.00	0.60	0.00	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	26.14	0.55	1.47	0.18	0.00	0.18	0.18	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	69.68	1.81	1.45	5.08	8.35	0.73	0.00	1.09	0.73	1.09
Neural stem cells, donor2	11352-117H2	94.36	3.85	0.00	3.85	5.78	0.00	0.00	0.00	9.63	0.00
Neurons, donor1	11494-119E9	54.62	2.28	1.14	5.69	1.14	0.00	2.28	1.14	1.14	0.00
Neurons, donor2	11574-120E8	34.57	1.54	1.54	3.74	3.30	0.44	0.00	0.22	0.44	0.44
Neurons, donor3	11655-122E8	41.11	4.93	0.00	2.47	0.00	0.00	0.00	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	87.86	10.45	7.60	7.48	5.11	1.07	4.16	5.22	2.37	2.85
Nucleus Pulposus Cell, donor2	11409-118E5	82.70	11.72	8.79	4.88	4.88	1.95	4.23	10.09	1.63	5.54
Nucleus Pulposus Cell, donor3	11462-119B4	61.77	9.83	1.80	3.41	1.60	0.60	1.80	0.40	2.41	1.00
Olfactory epithelial cells, donor1	11933-125I7	87.41	17.89	4.82	9.36	4.54	1.10	6.06	0.83	3.17	0.55
Olfactory epithelial cells, donor2	11934-125I8	83.37	17.51	0.58	6.66	3.62	1.16	5.36	0.14	3.18	0.29
Olfactory epithelial cells, donor3	11935-125I9	76.62	13.73	2.16	4.43	2.61	0.91	3.41	0.11	1.93	0.00
Olfactory epithelial cells, donor4	11936-126A1	85.22	17.43	2.82	6.92	3.51	1.95	3.70	0.68	2.82	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	42.13	12.04	0.60	4.21	3.61	4.81	3.61	0.60	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	61.68	19.36	4.25	3.40	2.77	0.64	12.55	1.06	2.98	1.28
Osteoblast - differentiated, donor2	11353-117H3	35.44	11.43	20.58	2.29	4.57	0.00	4.57	2.29	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	63.93	14.28	30.41	8.07	1.24	0.62	2.48	2.48	2.48	6.83
Osteoblast, donor1	11277-116H8	108.27	23.06	0.78	17.98	13.88	1.56	6.06	0.59	3.71	0.00
Osteoblast, donor2	11354-117H4	66.02	25.99	0.00	8.43	10.53	1.40	4.21	0.00	3.51	0.00
Osteoblast, donor3	11426-118G4	67.00	19.91	0.89	6.22	6.40	1.07	5.69	0.53	5.15	0.00
Pancreatic stromal cells, donor1	11249-116E7	37.65	12.21	11.96	3.79	1.94	0.51	3.71	4.63	1.52	2.86
Pericytes, donor1	11491-119E6	41.17	4.45	11.24	2.78	1.34	0.00	0.78	5.79	0.56	10.46
Pericytes, donor2	11571-120E5	61.57	4.98	2.26	3.40	3.17	0.00	0.91	1.36	2.26	2.94
Pericytes, donor3	11652-122E5	68.36	19.94	0.61	9.77	3.05	1.22	5.09	1.83	4.48	1.83
Perineurial Cells, donor1	11499-119F5	80.92	13.22	0.23	9.15	6.10	0.90	2.37	0.45	3.73	0.79
Perineurial Cells, donor2	11579-120F4	64.13	18.49	0.28	8.65	5.80	1.01	5.34	0.28	2.48	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.94	0.64	9.24	0.96	0.00	0.00	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.69	0.49	9.79	0.49	0.00	0.00	0.00	0.00	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.49	0.65	12.17	0.26	0.26	0.00	0.65	0.13	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	74.38	12.44	0.00	11.48	1.20	4.54	4.30	0.24	4.30	0.00
Placental Epithelial Cells, donor2	11355-117H5	114.22	22.18	0.00	6.65	8.87	2.22	1.11	0.00	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	107.78	18.85	0.00	13.55	3.53	0.59	5.69	0.00	5.30	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	49.05	6.96	1.58	5.06	1.27	1.90	1.58	0.63	1.27	0.00
Preadipocyte - breast, donor1	11467-119B9	47.08	6.38	2.25	4.50	2.63	0.38	2.25	1.13	1.31	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.32	5.35	1.96	1.83	1.70	0.78	1.57	1.04	2.35	0.91
Preadipocyte - breast, donor2	11328-117E5	55.39	7.20	0.68	4.73	4.73	1.13	0.68	0.68	3.15	0.45
Preadipocyte - omental, donor1	11468-119C1	48.70	7.99	4.37	5.11	2.56	0.43	1.60	2.66	1.39	2.02
Preadipocyte - omental, donor2	11329-117E6	57.61	10.91	0.87	4.36	2.62	2.18	2.62	0.00	3.06	0.44
Preadipocyte - omental, donor3	11403-118D8	53.86	12.89	0.14	6.02	2.01	0.29	3.29	1.00	2.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	52.17	13.78	0.98	7.87	2.95	0.98	0.00	1.97	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	90.91	34.40	0.92	15.05	7.68	0.61	6.76	0.31	3.69	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	59.14	29.57	0.18	14.34	6.55	0.71	6.37	0.35	5.14	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	51.94	21.29	0.34	6.98	5.62	1.36	6.30	0.34	4.43	0.00
Preadipocyte - visceral, donor1	11280-116I2	52.26	16.95	1.21	10.71	6.89	1.21	3.45	1.40	1.58	0.28
Preadipocyte - visceral, donor2	11357-117H7	51.08	22.09	0.92	8.28	4.14	0.46	2.30	0.00	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	42.84	15.36	0.63	8.57	2.93	1.15	2.93	0.73	2.93	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.36	4.07	0.75	5.88	14.33	0.00	1.51	0.00	0.45	0.00
Prostate Epithelial Cells, donor2	11331-117E8	22.48	8.26	0.14	2.57	2.71	4.60	1.62	0.00	1.08	0.00
Prostate Epithelial Cells, donor3	11404-118D9	30.62	4.04	0.00	2.33	1.10	14.94	1.10	0.00	0.49	0.00
Prostate Stromal Cells, donor1	11254-116F3	42.03	9.57	0.00	5.35	3.76	1.37	1.94	0.00	2.05	0.00
Prostate Stromal Cells, donor2	11332-117E9	42.14	12.01	0.54	5.20	3.59	0.54	1.61	0.18	2.15	0.00
Prostate Stromal Cells, donor3	11405-118E1	47.55	13.87	4.28	4.80	3.02	0.94	3.55	0.63	2.09	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	70.08	8.03	0.36	5.11	10.22	9.49	2.19	0.36	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	34.93	6.72	0.21	3.67	6.58	4.16	2.50	0.07	0.49	0.07
Renal Epithelial Cells, donor1	11517-119H5	108.04	23.84	0.51	16.74	30.94	6.59	10.65	0.00	6.09	0.51
Renal Epithelial Cells, donor2	11597-120H4	79.67	10.67	0.71	9.25	12.09	9.25	2.13	0.00	2.85	0.00
Renal Epithelial Cells, donor3	11678-122H4	47.64	7.41	0.32	3.81	8.26	3.71	2.33	0.00	0.85	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	58.55	21.11	0.68	8.85	2.04	1.36	0.00	0.00	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	59.43	15.09	0.67	7.82	2.70	1.21	1.89	0.13	2.16	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	46.62	11.99	0.00	8.66	7.55	1.78	3.55	0.00	1.55	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	99.15	13.97	0.00	15.31	8.65	3.33	0.67	0.00	2.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	65.15	20.91	0.22	9.46	18.71	3.96	6.82	0.22	2.20	0.66
Renal Mesangial Cells, donor2	11598-120H5	77.12	6.27	0.00	8.15	20.69	3.76	3.76	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	70.46	11.65	0.83	12.21	18.86	3.88	5.27	0.55	2.50	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	41.87	15.03	0.00	11.01	17.18	12.35	3.76	0.00	1.88	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	31.21	10.96	0.00	5.90	5.48	8.01	2.11	0.00	2.53	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	63.06	12.15	0.19	9.64	11.38	6.56	3.09	0.19	2.12	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	26.45	3.89	5.19	4.41	6.22	2.07	0.52	0.78	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	39.23	6.25	11.37	3.98	7.11	1.42	0.28	1.14	1.42	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	53.51	8.23	2.06	7.20	4.12	0.00	3.09	0.00	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.84	1.51	14.80	1.25	1.51	0.75	0.75	0.50	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.61	3.74	17.91	3.47	56.80	3.61	0.53	3.21	0.94	2.14
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	0.00	0.00	0.89	1.79	0.00	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.86	1.65	0.00	1.10	1.10	0.00	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.76	1.74	0.00	1.16	0.58	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.91	1.04	0.00	1.30	1.17	0.39	0.26	0.00	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	16.19	1.99	0.00	1.89	1.19	0.00	0.50	0.00	0.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	13.27	1.56	0.00	1.67	0.67	0.11	0.45	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.38	1.74	0.00	1.61	0.99	0.00	0.25	0.00	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.85	1.17	0.00	2.33	0.93	0.12	0.58	0.00	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.25	1.16	0.00	2.31	1.39	0.00	0.46	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.69	0.55	0.00	0.68	0.55	0.00	0.27	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.46	0.61	0.00	1.51	1.82	0.00	0.45	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	11.29	0.90	0.00	1.25	0.54	0.36	0.18	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.34	1.43	0.00	0.72	0.86	0.29	0.29	0.00	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	11.38	1.40	0.00	1.07	0.64	0.11	0.11	0.00	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.48	0.89	0.00	2.43	0.66	0.00	0.00	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.72	0.57	0.00	0.57	1.34	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.51	1.21	0.00	2.61	0.75	0.19	0.37	0.00	0.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	14.84	0.38	0.00	1.69	2.63	0.00	0.19	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.07	0.80	0.00	1.99	1.19	0.40	0.00	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.42	0.78	0.00	3.21	1.17	0.10	0.29	0.00	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.28	0.95	0.00	1.15	0.95	0.19	0.19	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.78	1.17	0.00	2.14	1.17	0.21	0.00	0.00	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.89	0.56	0.00	1.68	0.00	0.56	0.28	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	12.82	0.51	0.00	2.91	1.20	0.17	0.34	0.00	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.68	1.28	0.00	1.64	1.09	0.00	0.36	0.00	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	15.94	0.86	0.00	2.21	0.86	0.25	0.25	0.00	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	13.43	1.07	0.00	1.88	1.34	0.27	0.40	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	15.10	0.71	0.00	1.89	1.89	0.00	0.24	0.00	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.85	0.99	0.00	2.18	2.18	0.20	0.40	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.03	1.17	0.00	0.94	0.94	0.00	0.23	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.55	0.62	0.00	1.87	0.62	0.21	0.00	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	14.60	0.88	0.00	1.55	1.11	0.00	0.22	0.00	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.41	0.63	0.00	2.30	1.46	0.21	0.21	0.00	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.05	0.67	0.00	1.48	0.67	0.27	0.67	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	18.22	1.19	0.00	3.75	2.04	0.51	0.68	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.65	0.77	0.00	2.31	0.58	0.19	0.00	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.55	1.20	0.00	1.03	1.03	0.00	0.34	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.79	0.69	0.00	2.33	0.55	0.00	0.55	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.61	0.49	0.00	2.13	1.48	0.00	0.33	0.00	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.17	1.19	0.00	0.85	0.85	0.17	0.00	0.00	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.61	1.04	0.00	3.40	1.18	0.15	0.74	0.00	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.66	0.53	0.00	2.40	0.53	0.27	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.59	0.83	0.00	2.07	1.52	0.28	0.28	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.67	1.19	0.00	1.90	3.33	0.00	0.24	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	20.96	1.01	0.00	3.43	1.41	0.20	0.81	0.00	1.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.36	1.32	0.09	2.17	1.04	0.09	0.38	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.96	1.75	0.00	2.45	2.10	0.00	0.35	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.83	1.21	0.00	2.12	1.51	0.00	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.09	1.59	0.00	2.20	1.10	0.00	0.24	0.00	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	20.38	1.46	0.00	1.89	2.04	0.44	0.44	0.15	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.90	1.83	0.00	4.87	0.00	0.00	0.00	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.28	0.60	0.00	1.51	1.81	0.30	0.60	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	24.88	2.71	0.00	2.04	1.58	0.68	0.00	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	26.66	2.70	0.00	2.40	1.80	0.00	1.80	0.00	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.84	1.42	0.00	1.77	2.13	0.24	0.24	0.00	0.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.98	1.71	0.00	2.35	2.13	0.64	0.64	0.00	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	2.40	0.00	4.21	0.60	0.00	0.60	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	94.22	12.22	0.00	12.41	6.02	0.75	1.69	0.38	4.70	0.19
Schwann Cells, donor2	11578-120F3	51.04	0.00	0.00	10.21	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	47.98	5.48	0.00	5.48	5.26	0.88	1.75	0.00	1.97	0.00
Sebocyte, donor1	11220-116B5	107.36	20.27	0.00	12.05	4.93	14.79	2.19	0.00	6.57	0.00
Sebocyte, donor2	11301-117B5	55.61	11.49	0.00	5.06	2.76	9.65	1.38	0.00	1.84	0.00
Sebocyte, donor3	11378-118B1	63.07	10.51	0.41	4.95	2.27	4.12	3.09	0.00	2.47	0.21
Sertoli Cells, donor1	11255-116F4	84.49	11.60	1.66	11.60	1.66	0.00	0.00	0.00	4.97	0.00
Sertoli Cells, donor2	11333-117F1	39.54	14.12	5.65	11.30	0.00	0.00	0.00	8.47	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	81.64	6.42	0.26	4.40	6.07	1.06	1.67	0.35	1.85	0.09
Skeletal Muscle Cells, donor2	11358-117H8	75.90	13.73	7.23	11.57	2.17	0.72	3.61	0.72	4.34	0.00
Skeletal Muscle Cells, donor3	11430-118G8	136.27	26.75	0.84	18.39	7.52	2.51	5.02	0.00	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	33.15	7.54	0.31	5.97	2.20	0.63	1.57	0.47	2.83	0.31
Skeletal Muscle Cells, donor5	11455-119A6	38.35	7.58	0.15	4.61	3.72	0.15	1.78	0.30	2.23	0.15
Skeletal Muscle Cells, donor6	11459-119B1	41.71	11.23	0.15	6.00	2.62	1.54	2.00	0.77	2.77	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	58.72	9.83	1.13	7.69	3.15	1.01	2.27	2.14	1.64	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	61.07	11.56	1.14	7.56	3.42	1.71	3.57	1.71	2.43	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	45.34	9.42	0.69	8.04	3.97	0.69	1.79	0.60	1.88	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	62.77	12.81	0.17	8.85	6.07	0.17	5.73	0.17	1.94	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	102.77	15.20	0.72	10.13	9.41	1.45	2.17	0.72	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	55.73	14.04	0.41	5.78	4.68	0.96	2.61	0.28	3.03	0.69
Skin - palm, donor1	10286-104F7	102.07	0.00	104.76	0.00	2.69	2.69	0.00	21.49	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	20.61	6.92	0.14	1.01	1.15	2.31	1.87	0.00	1.44	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	9.81	0.00	0.00	0.82	4.91	0.82	0.00	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.10	10.78	0.00	1.69	0.91	4.28	2.21	0.00	1.95	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	36.28	6.12	0.14	1.39	1.53	6.95	1.95	0.14	0.83	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	41.63	11.11	0.14	1.97	1.97	8.16	1.83	0.00	1.69	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.09	15.01	0.00	1.90	2.11	5.71	1.27	0.00	4.44	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	47.97	6.97	0.07	4.20	2.10	13.04	2.17	0.00	1.72	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	71.59	16.35	0.31	5.86	5.86	4.01	5.55	0.00	2.47	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.01	8.00	0.00	1.78	0.89	1.56	1.56	0.00	1.78	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	73.48	25.86	0.00	10.58	4.70	2.35	6.47	0.00	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	72.71	15.69	0.44	6.63	3.09	2.21	4.86	0.00	2.43	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	70.88	27.96	0.00	11.42	5.51	0.79	5.12	0.00	3.15	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	88.85	23.95	0.00	11.59	9.27	3.86	5.41	0.00	3.09	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	75.06	15.01	1.00	7.01	8.01	0.00	1.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	80.91	19.83	0.00	9.45	3.59	3.06	5.86	0.00	2.26	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.67	13.52	2.88	4.65	2.44	0.89	3.99	3.10	1.55	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.65	3.33	0.00	1.28	0.77	0.64	0.64	0.00	0.90	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.23	2.28	1.95	0.98	3.26	0.00	0.65	0.65	1.30	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.37	10.04	7.09	2.36	1.77	0.00	1.48	2.07	1.77	3.84
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.61	10.82	2.56	4.98	2.14	1.14	2.99	0.43	1.71	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	71.58	32.05	3.58	12.20	7.16	1.30	8.78	0.81	4.88	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	37.14	10.05	22.83	3.96	0.91	0.30	3.65	4.26	0.91	6.70
Smooth Muscle Cells - Carotid, donor1	11285-116I7	106.58	24.50	2.02	15.66	4.29	1.77	8.33	0.76	5.81	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	24.48	0.00	6.12	12.24	6.12	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	95.37	35.76	0.48	14.78	5.25	1.91	4.77	0.00	5.72	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.55	7.08	3.39	4.72	2.95	1.18	1.47	0.44	1.03	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	42.40	12.70	3.44	7.75	3.23	1.08	4.52	0.22	2.37	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.15	9.87	1.26	8.50	2.83	0.73	3.67	0.31	2.52	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	92.65	29.54	0.15	12.06	5.72	2.94	7.58	0.00	3.40	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	54.97	18.32	0.00	5.39	2.16	1.08	6.47	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.33	11.36	0.00	4.48	3.29	0.60	2.69	0.00	3.29	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	97.98	26.29	1.71	20.14	14.34	2.39	8.19	0.68	4.10	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	84.10	13.66	1.26	6.60	3.53	1.10	2.98	0.31	1.88	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.07	15.20	1.61	3.02	2.52	0.40	5.13	0.20	1.11	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	62.80	23.21	1.37	10.47	3.19	0.91	5.46	0.23	4.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	73.66	32.61	0.00	9.66	3.62	1.81	4.23	0.00	4.83	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	60.40	11.39	0.00	12.19	5.56	2.12	2.91	0.00	1.85	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.20	17.44	1.60	5.19	3.86	1.33	3.06	0.27	2.66	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	47.96	10.02	0.38	5.38	2.63	0.88	2.13	0.25	1.50	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.94	5.33	73.82	1.27	0.51	0.00	0.76	9.39	0.76	7.36
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	87.90	25.78	0.30	14.32	6.78	0.75	7.54	0.00	4.22	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	92.27	24.01	3.75	9.00	2.25	2.25	3.00	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	11.63	0.00	2.58	2.58	0.00	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	100.92	26.04	0.47	16.74	6.98	2.79	4.19	0.47	5.58	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	72.70	16.16	1.01	7.07	5.55	1.01	2.52	0.00	4.54	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	45.44	17.24	1.25	7.83	2.19	1.57	3.45	0.00	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	41.59	16.81	12.68	3.54	3.83	1.47	3.24	0.29	0.88	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	66.73	18.99	0.17	9.83	5.75	2.33	4.42	0.33	2.58	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	61.20	16.82	19.15	3.74	2.34	0.00	4.20	2.80	1.87	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	59.73	14.10	0.14	5.90	2.88	2.16	2.88	0.14	3.45	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	83.12	21.16	0.76	11.47	4.84	1.53	5.10	0.00	3.31	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	76.15	23.13	0.00	9.21	5.83	1.88	5.64	0.00	4.32	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	54.92	14.39	0.00	6.99	4.33	1.54	3.91	0.00	2.93	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	52.87	18.27	0.00	4.86	2.18	0.75	7.04	0.00	2.60	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	62.86	10.48	2.38	3.81	2.38	1.43	4.76	0.00	1.43	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	59.70	15.66	0.00	3.91	3.18	0.73	4.16	0.00	3.43	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.70	19.22	0.00	3.54	4.42	0.44	4.20	0.00	3.76	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	47.98	16.68	0.59	8.19	6.44	3.22	4.10	0.00	2.05	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.82	6.80	35.57	3.89	0.58	0.00	2.92	2.92	0.58	3.50
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.48	5.02	6.35	2.38	1.85	0.53	2.12	1.85	0.53	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	4.09	7.44	1.49	1.12	0.37	1.12	1.12	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	26.59	8.26	16.89	1.44	1.80	0.00	2.16	1.80	1.08	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.55	5.68	0.85	1.70	1.14	1.14	1.99	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	46.48	9.45	1.18	4.33	3.54	1.97	1.97	0.00	2.76	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	21.84	4.06	12.70	2.03	0.76	0.00	1.27	2.79	0.25	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	29.55	6.39	19.57	2.80	0.40	0.40	2.00	2.40	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	19.65	5.43	35.53	0.84	0.42	0.42	2.51	3.76	0.00	5.85
Smooth muscle cells - airway, control, donor4	11969-126D7	36.21	4.58	31.17	1.83	0.92	0.00	2.29	4.13	0.92	4.58
Synoviocyte, donor1	11291-117A4	23.23	7.91	8.08	2.19	2.02	0.00	3.87	18.85	1.35	13.97
Synoviocyte, donor2	11368-117I9	54.14	10.39	16.26	5.53	1.34	1.84	2.01	6.54	1.84	6.37
Synoviocyte, donor3	11440-118H9	50.27	8.49	13.40	5.59	1.34	0.45	1.12	6.03	2.68	4.69
Trabecular Meshwork Cells, donor1	11532-120A2	117.20	29.30	1.79	14.29	11.79	1.79	4.29	1.07	5.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	77.30	17.84	1.98	5.95	3.96	3.96	0.00	0.00	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	119.48	21.30	1.16	18.29	5.33	3.24	4.40	0.00	4.40	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	37.13	7.46	0.07	4.73	2.01	7.74	1.58	0.00	1.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	57.21	11.21	0.00	4.25	3.48	6.57	2.32	0.00	2.71	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	52.11	14.89	0.00	5.15	1.15	9.16	3.44	0.00	3.44	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.57	2.83	16.61	4.31	57.82	2.95	0.74	3.32	0.86	3.08
Urethra, donor2	10319-105A4	73.74	1.80	25.18	7.19	1.80	7.19	1.80	10.79	1.80	3.60
Urothelial Cells, donor1	11520-119H8	33.21	11.16	0.00	2.66	2.39	7.70	1.33	0.00	1.06	0.00
Urothelial Cells, donor2	11600-120H7	20.03	4.81	0.00	2.40	0.80	2.40	0.40	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	31.86	4.35	0.00	0.69	0.92	2.75	1.38	0.00	2.06	0.00
Urothelial cells, donor0	11216-116B1	37.89	8.92	0.00	2.67	1.56	4.46	2.23	0.00	2.01	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	12.46	0.00	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	10.01	0.00	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.79	0.00	0.68	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	15.84	0.00	2.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	12.20	0.00	3.49	0.00	0.00	0.00	0.00	1.16	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	0.00	2.08	0.00	0.00	0.00	0.00	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	0.00	4.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	7.30	0.00	2.74	0.00	0.00	0.00	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	84.26	7.15	0.00	7.03	4.07	0.25	1.23	0.00	0.99	0.00
Wilms' tumor cell line:HFWT	10597-108E3	70.40	5.28	0.00	10.56	22.88	3.52	1.76	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.07	1.40	0.84	4.19	1.40	2.51	0.28	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	37.20	0.00	84.73	4.13	2.07	0.00	0.00	20.67	0.00	20.67
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.82	0.00	2.04	0.25	0.00	0.00	0.00	5.86	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	9.75	0.70	0.00	0.46	0.00	0.00	0.23	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	62.04	4.08	0.00	10.07	0.27	0.00	1.09	0.00	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.22	0.00	0.00	0.84	0.00	0.00	0.56	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	36.37	4.23	0.21	2.11	0.21	0.85	1.90	0.00	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	49.54	3.27	0.00	2.45	0.54	0.27	0.54	0.00	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.63	2.72	0.00	2.33	0.00	0.00	0.39	0.39	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	3.90	0.00	7.80	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	70.88	11.15	0.23	7.44	1.16	0.23	4.88	0.00	3.72	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	55.15	6.21	0.00	3.62	1.04	0.00	3.88	0.00	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	33.61	3.21	0.00	1.17	0.29	0.58	0.88	0.00	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.58	2.79	0.00	4.65	1.86	2.32	1.39	0.00	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.49	5.35	0.00	1.65	0.41	0.00	2.06	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	96.08	11.36	0.00	7.06	2.15	0.00	1.23	0.00	2.76	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	38.40	6.83	0.00	4.27	1.28	0.43	2.99	0.00	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	35.18	6.98	0.00	6.37	1.52	0.30	2.43	0.00	2.73	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	40.68	7.22	0.00	6.74	2.41	0.24	0.72	0.00	1.93	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.71	2.23	0.00	2.90	0.00	0.00	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	10.55	0.75	0.00	4.52	0.38	0.00	0.75	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	4.24	0.47	0.00	0.24	1.65	4.47	0.00	0.00	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	49.17	1.40	46.23	3.41	1.86	2.64	0.47	19.23	1.09	10.39
adipose, donor1	10184-103D4	48.09	0.00	0.00	2.35	4.69	0.00	0.00	0.00	0.59	0.00
adipose, donor2	10185-103D5	89.21	1.62	0.41	3.65	12.57	0.00	0.81	0.00	1.22	0.00
adipose, donor3	10186-103D6	56.91	1.09	0.00	3.81	4.90	0.00	0.27	0.00	0.82	0.00
adipose, donor4	10187-103D7	42.47	1.73	0.00	2.60	3.47	0.00	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	84.43	5.37	0.00	14.20	5.68	3.16	0.47	0.00	3.95	0.00
adrenal gland, adult, pool1	10081-102A9	43.65	0.00	14.55	3.64	3.64	3.64	0.00	3.64	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.68	4.40	0.00	3.20	0.40	0.80	1.73	0.00	0.93	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	32.51	4.64	0.00	2.50	3.57	1.43	0.00	0.00	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	40.34	9.74	0.00	2.09	1.16	7.88	1.39	0.00	3.25	0.00
amniotic membrane cells, donor2	12236-129G4	24.01	14.88	0.68	6.76	1.01	7.78	5.41	0.00	4.73	0.00
amniotic membrane cells, donor3	12237-129G5	47.14	7.37	0.29	1.47	0.29	12.96	1.47	0.00	2.06	0.00
amygdala - adult, donor10196	10167-103B5	21.34	0.00	13.04	2.37	1.19	0.00	0.00	1.19	0.00	2.37
amygdala, adult, donor10252	10151-102I7	39.54	2.03	26.77	3.04	1.42	0.20	0.61	6.29	0.81	9.94
amygdala, newborn, donor10223	10360-105E9	13.56	0.97	6.46	0.65	0.97	0.32	0.32	3.23	0.00	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	45.20	4.46	0.00	2.42	4.97	2.93	2.04	0.00	0.76	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	79.83	7.68	0.00	3.34	18.04	7.01	2.34	0.00	2.34	0.00
aorta, adult, pool1	10052-101G7	73.35	6.08	48.84	5.10	1.96	2.16	1.77	22.56	2.94	11.96
appendix, adult	10189-103D9	43.08	1.94	11.26	2.72	5.05	0.39	0.39	1.55	0.39	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	2.41	0.00	0.34	0.34	3.44	0.00	0.00	7.91	0.00	4.82
artery, adult	10190-103E1	25.82	2.72	32.61	4.08	0.00	0.00	1.36	27.17	0.00	13.59
astrocytoma cell line:TM-31	10425-106D2	48.68	4.20	0.00	5.22	8.40	0.87	1.01	0.00	1.59	0.00
b cell line:RPMI1788	10427-106D4	1.19	0.00	1.64	0.15	0.15	0.00	0.00	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.93	17.20	1.94	4.99	1.66	1.66	7.49	0.55	2.77	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.69	5.76	0.30	2.38	3.47	8.04	1.69	0.00	1.29	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	1.84	0.33	0.00	0.00	0.33	4.52	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	56.48	3.91	1.68	0.00	0.56	0.00	2.24	0.56	0.56	0.00
bladder, adult, pool1	10011-101C2	60.95	3.04	19.77	4.56	1.41	1.52	1.52	10.76	1.20	5.00
blood, adult, pool1	10053-101G8	15.50	0.00	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	53.09	27.40	0.00	6.85	2.57	0.86	4.28	0.00	2.57	0.00
bone marrow, adult	10192-103E3	30.37	0.67	26.99	1.35	0.67	0.00	0.67	4.72	0.67	1.35
brain, adult, donor1	10084-102B3	26.65	3.08	14.35	2.05	5.13	0.00	1.03	4.10	0.00	4.10
brain, adult, pool1	10012-101C3	20.71	1.22	15.92	2.00	2.00	0.22	0.22	2.67	0.22	3.45
brain, fetal, pool1	10085-102B4	37.40	0.00	0.00	8.01	0.00	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.21	0.99	0.33	0.99	0.66	3.96	0.00	0.00	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	51.77	1.89	33.46	5.05	1.89	0.63	0.63	12.00	0.63	10.73
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	36.71	7.24	0.13	2.29	0.76	5.46	1.14	0.13	0.89	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	48.86	3.40	0.31	1.86	2.78	12.99	0.31	0.00	1.55	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	21.87	5.06	0.00	7.83	1.15	1.61	1.15	0.00	1.15	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	18.40	0.97	0.48	2.66	0.48	1.45	0.00	0.00	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	19.75	1.41	0.00	3.29	0.47	1.41	0.00	4.70	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	12.58	0.44	0.55	1.31	2.41	1.86	0.22	0.33	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	48.80	1.27	0.00	4.44	0.63	0.00	0.00	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	73.47	3.73	2.66	9.85	3.46	0.27	1.06	2.93	1.86	2.40
caudate nucleus - adult, donor10196	10177-103C6	24.18	0.00	14.97	1.15	1.15	0.00	1.15	0.00	1.15	3.45
caudate nucleus, adult, donor10252	10164-103B2	45.18	1.17	21.25	2.34	2.18	0.17	0.50	5.02	1.00	7.36
caudate nucleus, adult, donor10258	10379-105H1	22.92	1.53	19.10	1.53	0.00	0.00	0.00	2.29	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	31.86	1.83	12.09	1.83	0.00	0.00	0.00	4.76	0.00	4.39
cerebellum - adult, donor10196	10173-103C2	75.75	2.91	14.57	2.91	14.57	2.91	0.00	2.91	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	90.10	7.26	16.01	3.20	17.72	5.76	0.43	4.91	4.91	6.19
cerebellum, adult, pool1	10083-102B2	51.40	3.45	13.45	2.41	7.59	3.45	0.00	3.79	1.72	1.72
cerebellum, newborn, donor10223	10357-105E6	13.28	0.00	7.47	0.83	2.49	0.83	0.00	0.83	0.00	1.66
cerebral meninges, adult	10188-103D8	25.72	1.76	16.14	1.01	1.51	0.50	0.25	3.53	0.50	5.80
cerebrospinal fluid, donor2	10294-104G6	13.16	0.73	15.35	0.00	0.00	0.00	0.00	2.92	0.73	2.92
cervical cancer cell line:D98-AH2	10552-107I3	44.14	2.01	0.00	2.01	1.29	16.25	0.58	0.00	1.29	0.00
cervical cancer cell line:ME-180	10553-107I4	36.13	3.98	0.17	2.98	1.16	4.81	0.33	0.00	0.83	0.00
cervix, adult, pool1	10013-101C4	76.64	7.45	42.31	5.77	4.30	4.62	3.67	21.84	1.36	13.02
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.11	2.37	0.00	2.79	2.37	0.56	0.42	0.00	0.56	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	39.19	0.00	0.00	6.53	2.61	1.31	1.31	0.00	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	40.76	2.36	0.00	3.98	3.98	0.00	0.25	0.00	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	38.81	1.60	0.00	8.26	1.36	0.00	0.25	0.00	0.86	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	18.03	1.19	0.24	4.74	1.19	0.00	0.24	0.00	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	43.31	6.27	0.85	1.99	1.99	1.42	1.42	2.28	1.99	0.28
chorionic membrane cells, donor2	12239-129G7	38.78	16.21	0.40	4.18	3.38	1.59	3.18	0.10	4.47	0.10
chorionic membrane cells, donor3	12240-129G8	45.06	2.20	4.95	1.10	0.55	0.00	0.00	2.20	3.30	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.30	3.07	0.00	2.88	1.54	0.19	1.34	0.00	1.73	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	11.62	2.11	0.42	0.63	0.42	0.21	0.42	0.00	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.34	1.03	0.00	0.26	0.26	0.00	0.51	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	3.87	1.45	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.09	0.41	0.00	0.00	0.41	0.00	0.20	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	5.89	0.88	0.00	1.18	0.88	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	4.43	0.78	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	46.63	8.46	0.00	8.91	6.63	14.17	1.83	0.00	3.89	0.00
clear cell carcinoma cell line:TEN	10636-108I6	7.81	1.21	0.00	0.69	0.35	1.04	0.17	0.00	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	34.96	7.87	0.00	8.42	13.00	0.18	0.55	0.18	1.10	0.00
colon carcinoma cell line:COLO-320	10420-106C6	106.42	4.18	0.00	9.50	4.56	0.00	1.14	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	53.55	4.76	10.71	1.19	4.76	15.47	1.19	5.95	0.00	2.38
colon, adult, pool1	10014-101C5	39.95	2.47	12.57	2.12	19.86	10.46	0.35	3.06	1.53	2.82
colon, fetal, donor1	10070-101I7	61.18	1.85	10.51	1.24	6.80	4.33	0.00	3.09	1.24	2.47
common myeloid progenitor CMP, donor1	12130-128D6	36.67	0.00	4.58	0.00	0.00	4.58	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	6.80	1.70	0.00	0.85	0.42	0.42	0.00	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	9.81	3.62	0.00	1.66	2.41	0.60	0.75	0.00	0.60	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	9.59	3.10	0.00	1.97	1.97	0.42	0.28	0.00	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	35.82	1.11	33.94	2.32	1.55	0.33	0.55	6.97	0.44	6.85
cruciate ligament, donor2	10295-104G7	55.11	1.62	85.91	1.62	0.81	3.24	0.81	23.50	0.00	11.35
diaphragm, fetal, donor1	10069-101I6	39.33	5.62	10.43	4.01	0.80	0.80	0.80	16.05	0.80	12.04
diencephalon, adult	10193-103E4	11.52	0.72	15.36	0.24	0.48	0.00	0.24	1.68	0.24	4.08
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.57	0.77	0.00	0.77	1.80	2.05	0.77	0.00	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.15	5.06	0.00	3.85	1.20	1.44	0.48	0.00	0.96	0.00
ductus deferens, adult	10196-103E7	34.39	2.49	9.47	2.99	1.99	4.98	0.00	2.49	1.00	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	7.20	5.76	0.00	1.44	4.32	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.78	2.21	3.68	1.47	13.24	5.15	0.74	4.41	2.94	0.74
dura mater, adult, donor1	10041-101F5	97.29	7.35	51.70	8.92	4.54	2.15	1.73	19.08	2.06	14.62
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	41.75	2.66	0.00	3.11	5.11	0.22	1.33	0.00	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	56.03	4.73	0.00	7.02	17.05	0.29	1.00	0.00	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	38.85	1.85	0.00	1.85	1.85	4.32	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	31.48	4.54	0.00	1.51	1.51	3.94	0.30	0.00	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.57	2.78	0.00	2.47	3.40	2.78	0.00	0.00	1.23	0.00
embryonic pancreas cell line:2C6	10603-108E9	34.15	3.94	0.00	5.25	5.25	5.25	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	25.47	2.01	0.00	2.01	2.68	0.67	1.01	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	118.71	13.05	0.00	12.14	2.90	6.16	1.63	0.00	5.62	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.77	5.63	0.32	2.25	5.31	5.31	0.64	0.16	0.96	0.00
epidermoid carcinoma cell line:A431	10426-106D3	19.01	4.67	0.00	3.22	3.78	8.45	1.00	0.00	0.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	34.32	8.69	0.00	7.81	5.61	13.97	2.64	0.00	1.32	0.00
epididymis, adult	10197-103E8	42.07	3.56	32.65	3.14	2.09	2.51	0.84	11.09	0.21	7.95
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	44.35	11.71	0.00	13.66	5.85	2.13	1.06	0.00	4.08	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.41	1.57	0.00	4.72	1.97	2.36	1.57	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	33.02	3.28	0.00	6.42	4.59	12.19	0.39	0.00	3.28	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	48.72	3.84	0.00	9.74	5.81	17.91	0.98	0.00	1.77	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	39.32	5.27	0.00	6.61	5.38	13.56	0.78	0.00	2.35	0.00
esophagus, adult, pool1	10015-101C6	41.73	3.19	12.10	2.23	1.91	5.84	0.00	4.99	1.17	3.61
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	42.96	5.39	0.13	5.51	3.13	1.25	0.88	0.25	1.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	65.19	0.00	50.71	2.41	2.41	0.00	0.00	21.73	0.00	16.90
eye - muscle lateral, donor2	10298-104H1	42.08	0.00	52.61	8.42	2.10	0.00	0.00	14.73	0.00	10.52
eye - muscle medial, donor2	10299-104H2	71.43	2.98	47.62	1.49	2.98	0.00	1.49	8.93	0.00	5.95
eye - muscle superior, donor2	10297-104G9	50.45	2.29	33.25	2.29	0.00	0.00	0.00	10.32	2.29	17.20
eye - vitreous humor, donor1	10268-104D7	21.86	0.00	43.72	4.37	2.91	0.00	0.00	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	42.97	2.54	18.56	4.32	2.03	0.25	2.54	6.61	1.27	6.36
fibrosarcoma cell line:HT-1080	10758-110E2	16.03	3.21	0.00	2.31	0.90	0.64	0.64	0.00	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	24.21	2.06	14.36	0.94	1.41	0.38	0.47	3.10	0.19	2.72
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.92	5.40	0.00	2.40	2.10	6.91	0.90	0.00	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	19.20	1.19	0.09	1.28	1.65	5.30	0.27	0.00	0.55	0.00
gall bladder, adult	10198-103E9	62.05	2.90	29.70	3.38	4.35	2.17	0.24	11.35	1.69	7.97
gamma delta positive T cells, donor1	11937-126A2	30.60	0.54	0.54	0.54	0.00	0.00	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	18.67	0.37	0.75	0.00	0.75	0.37	0.00	0.00	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.25	1.48	0.00	0.42	0.63	1.48	0.42	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.05	2.51	1.55	0.97	0.58	3.09	0.19	0.19	0.58	1.35
gastric cancer cell line:AZ521	10549-107H9	57.55	4.75	0.00	10.98	3.77	1.31	0.66	0.00	2.62	0.00
gastric cancer cell line:GSS	10560-108A2	59.49	1.83	0.00	6.41	4.58	0.92	0.00	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.56	1.37	0.69	2.97	5.25	0.23	0.23	2.28	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	6.54	0.46	0.00	0.23	1.03	5.16	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	16.10	2.38	0.00	1.26	2.10	2.24	0.84	0.00	0.56	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	13.72	1.00	0.00	2.74	0.75	7.73	0.25	0.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	61.01	5.91	0.11	8.02	7.92	4.43	1.06	0.00	2.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	65.73	6.32	0.14	8.85	9.13	2.25	2.39	0.00	2.95	0.00
glioblastoma cell line:T98G	10485-107A8	49.67	6.07	0.00	9.27	3.64	1.21	1.32	0.00	1.21	0.00
glioma cell line:GI-1	10413-106B8	82.30	9.96	0.00	11.13	7.32	2.34	4.69	0.00	3.81	0.00
globus pallidus - adult, donor10196	10175-103C4	9.48	0.00	26.24	2.19	0.00	0.00	0.73	0.73	0.00	2.19
globus pallidus, adult, donor10252	10161-103A8	51.99	1.22	38.32	3.42	2.93	0.24	0.98	9.03	0.49	6.83
globus pallidus, adult, donor10258	10367-105F7	16.43	0.00	21.91	0.00	1.37	1.37	4.11	2.74	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	23.98	0.53	7.99	2.13	1.60	0.53	0.00	4.26	0.53	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	9.79	7.34	12.24	0.00	0.00	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	38.40	5.12	0.00	2.56	3.20	0.96	1.60	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	55.09	2.30	0.00	3.21	2.75	0.00	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	48.93	1.37	1.83	0.91	6.40	0.00	0.46	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	50.88	3.86	0.00	1.29	2.58	0.64	0.64	0.00	1.93	0.00
hIPS, biol_rep1	14380-156B6	18.68	1.44	0.00	1.44	7.19	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	37.72	0.69	0.69	2.06	0.69	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	17.66	1.10	32.00	1.10	2.21	0.00	1.10	1.10	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	1.72	0.00	0.00	1.44	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	59.20	2.99	15.85	7.47	1.79	0.60	1.49	12.26	0.30	8.97
heart - pulmonic valve, adult	10206-103F8	56.22	3.40	23.27	4.18	2.09	1.31	0.00	9.41	1.05	5.23
heart - tricuspid valve, adult	10207-103F9	34.97	4.16	13.32	7.49	0.83	1.67	2.50	16.65	0.83	10.82
heart, adult, diseased post-infarction, donor1	10050-101G5	41.63	4.08	5.92	6.53	1.22	3.06	0.61	2.04	1.63	1.63
heart, adult, diseased, donor1	10051-101G6	58.76	5.11	10.22	5.96	5.11	7.66	3.83	9.79	0.43	3.83
heart, adult, pool1	10016-101C7	42.32	2.76	6.44	5.06	1.38	2.53	0.92	5.98	0.92	2.76
heart, fetal, pool1	10046-101G1	86.15	7.29	8.52	9.45	5.54	4.21	1.85	11.19	1.33	4.83
hepatic mesenchymal tumor cell line:LI90	10778-110G4	51.52	14.81	0.00	7.10	2.78	0.93	3.70	0.31	2.16	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	0.00	4.76	0.00	0.00	0.00	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.44	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.24	0.00	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.00	0.00	0.71	0.00	0.00	0.00	0.00	0.61	0.00	0.20
hepatoma cell line:Li-7	10484-107A7	17.79	0.22	0.00	2.11	9.23	5.89	0.00	0.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	7.04	1.01	0.10	0.30	0.00	0.00	0.30	0.00	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	8.52	0.00	18.93	0.95	1.89	0.00	0.00	2.84	0.00	7.57
hippocampus, adult, donor10252	10153-102I9	50.21	0.82	38.98	3.27	1.43	0.41	0.20	8.57	0.61	13.06
hippocampus, adult, donor10258	10374-105G5	10.95	1.49	19.42	0.50	3.98	0.00	0.50	0.00	0.00	4.48
hippocampus, newborn, donor10223	10363-105F3	15.86	0.35	7.05	2.11	1.06	0.00	0.35	2.47	0.35	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	18.92	1.22	0.61	3.05	1.22	0.61	0.00	0.00	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	35.34	0.98	0.00	4.32	2.16	0.20	0.00	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	34.53	0.51	0.51	2.79	2.03	0.00	0.25	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	78.38	1.13	0.00	5.07	3.95	0.00	1.13	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	93.47	1.03	0.26	3.87	2.32	0.00	0.26	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	85.03	1.52	0.00	3.42	3.42	0.00	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	52.55	1.46	0.00	2.04	3.21	0.29	0.58	0.00	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	66.35	1.51	0.22	5.17	6.03	0.00	0.00	0.00	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	62.98	0.83	0.00	3.34	5.84	0.00	0.42	0.00	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	44.75	1.89	0.00	3.55	2.84	0.24	0.24	0.00	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	67.82	2.41	0.00	4.34	5.79	0.00	0.16	0.00	0.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	39.72	3.37	0.00	7.41	6.73	0.00	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	32.86	1.88	0.16	4.85	2.82	0.63	0.31	0.00	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	0.00	0.00	5.40	0.98	0.49	0.49	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	18.33	0.00	0.00	0.87	0.87	0.00	0.00	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	118.75	3.05	0.00	7.64	7.06	0.00	0.57	0.19	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	116.00	1.31	0.00	10.03	5.23	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	71.97	1.00	0.00	1.50	6.50	0.00	0.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	96.83	0.94	1.13	4.33	9.42	0.00	0.19	0.19	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	98.22	2.73	0.91	4.55	9.09	0.00	0.45	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	78.62	1.57	0.63	1.88	10.34	0.00	0.63	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	68.91	2.61	0.00	4.57	11.76	0.33	0.65	0.00	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	70.55	4.06	0.00	2.90	14.52	0.29	0.29	0.00	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	70.25	1.49	0.30	2.69	14.35	0.00	0.60	0.00	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	45.82	1.48	0.18	3.14	2.96	0.18	0.00	0.18	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	49.35	1.14	0.29	3.71	3.99	0.29	0.00	0.57	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	41.65	2.04	0.41	3.67	4.08	0.41	0.41	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	85.20	1.76	0.00	3.17	9.15	0.35	0.35	0.00	0.35	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	89.95	2.85	0.00	6.33	9.50	0.00	0.95	0.32	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	94.11	2.12	0.00	6.66	11.50	0.61	0.91	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	80.67	0.52	0.00	2.59	8.27	0.52	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	71.07	2.66	0.66	2.66	8.63	0.00	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	53.36	1.80	0.00	2.31	5.13	0.00	0.51	0.00	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	61.36	2.56	0.26	5.37	9.97	0.00	1.28	0.00	1.53	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	81.78	2.27	0.00	4.54	9.84	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	58.47	4.37	0.00	5.71	8.74	0.00	0.34	0.00	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	52.17	1.45	0.24	5.55	3.86	0.97	0.24	0.24	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	38.33	0.89	0.00	6.24	2.67	1.34	0.00	0.45	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	38.54	2.44	0.49	2.44	1.46	0.49	0.49	0.00	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	89.24	2.75	0.00	3.06	7.95	0.61	0.31	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	0.00	0.00	0.00	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	65.20	0.66	0.00	5.63	5.96	0.00	0.33	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	81.00	2.74	0.00	4.93	8.76	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	73.10	1.45	0.00	3.62	4.70	0.00	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	54.09	1.07	0.00	3.56	3.91	0.00	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	58.48	1.19	0.00	2.39	8.35	0.00	1.19	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	79.22	2.98	0.00	7.04	9.89	0.14	0.27	0.00	0.81	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	53.07	0.54	0.00	3.50	8.08	0.00	0.54	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	17.19	0.97	9.44	0.24	0.48	2.91	0.24	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	14.26	1.58	7.13	1.58	0.00	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	21.58	1.70	16.09	1.51	1.99	0.09	0.47	4.35	0.38	5.68
keratoacanthoma cell line:HKA-1	10791-110H8	64.38	7.15	0.00	4.55	1.30	1.30	2.28	0.00	3.25	0.00
kidney, adult, pool1	10017-101C8	36.45	3.60	5.71	4.71	26.23	3.70	1.40	3.70	0.50	1.60
kidney, fetal, pool1	10045-101F9	66.99	9.05	5.94	6.79	33.39	2.83	3.61	4.53	1.49	2.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	38.20	6.53	0.14	2.84	2.41	2.84	1.99	0.00	1.42	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	21.70	0.41	0.00	2.76	0.28	1.38	0.14	0.00	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	47.16	6.24	0.00	3.49	3.85	8.07	2.94	0.00	0.55	0.00
left atrium, adult, donor1	10079-102A7	35.42	1.63	44.68	2.72	1.63	0.00	1.09	4.36	1.09	3.81
left ventricle, adult, donor1	10078-102A6	48.04	3.03	8.09	4.05	1.01	2.02	1.01	2.53	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	69.22	8.48	0.00	12.04	4.65	2.19	2.74	0.00	2.74	0.00
leiomyoma cell line:10964C	10569-108B2	32.69	6.47	0.36	3.23	2.16	2.51	1.80	0.00	1.08	0.00
leiomyoma cell line:15242A	10570-108B3	15.76	3.80	0.54	3.26	1.09	0.54	3.80	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	36.42	8.26	0.00	1.94	3.16	2.19	1.94	0.00	2.43	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	38.69	3.14	2.09	5.23	5.23	4.18	3.14	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	11.69	0.71	0.00	0.94	0.24	0.12	0.12	0.00	0.24	0.00
liposarcoma cell line:KMLS-1	10782-110G8	29.21	5.31	0.00	3.59	3.44	2.19	0.62	0.00	2.03	0.16
liposarcoma cell line:SW 872	10726-110A6	29.49	6.09	0.00	4.14	1.71	0.24	0.85	0.12	1.46	0.00
liver, adult, pool1	10018-101C9	16.04	1.78	4.05	2.59	68.39	4.86	0.32	0.49	0.00	0.97
liver, fetal, pool1	10086-102B5	15.05	3.76	7.53	5.64	21.64	0.00	0.94	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	24.06	0.44	29.02	1.90	0.44	0.00	0.15	3.21	0.15	2.62
locus coeruleus, adult, donor10252	10165-103B3	30.27	0.92	25.65	2.77	1.29	0.18	0.55	4.80	0.92	3.88
locus coeruleus, adult, donor10258	10375-105G6	22.01	0.56	28.21	0.56	0.56	0.00	0.85	2.82	0.85	4.51
locus coeruleus, newborn, donor10223	10362-105F2	16.82	0.42	3.79	0.84	0.84	0.84	0.00	1.26	0.00	5.05
lung adenocarcinoma cell line:A549	10499-107C4	18.54	2.08	0.00	4.71	4.29	4.71	0.14	0.00	0.97	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	13.10	0.69	0.00	1.38	1.38	4.83	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	8.70	0.40	0.00	0.92	0.79	4.48	0.00	0.00	0.13	0.00
lung, adult, pool1	10019-101D1	41.70	3.54	28.35	2.36	1.77	7.68	0.71	3.31	0.47	1.54
lung, fetal, donor1	10068-101I5	81.06	8.56	34.25	8.56	4.28	7.71	1.71	6.56	2.28	6.85
lung, right lower lobe, adult, donor1	10075-102A3	58.65	5.50	51.78	3.21	2.75	4.58	1.83	5.04	0.92	2.75
lymph node, adult, donor1	10077-102A5	35.98	1.42	13.73	4.73	0.47	0.95	0.95	5.21	0.47	3.31
lymphangiectasia cell line:DS-1	10727-110A7	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	20.39	2.55	0.00	1.70	0.85	5.10	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	61.27	1.33	4.44	5.33	0.44	1.33	0.44	3.55	2.66	0.89
mature adipocyte, donor2	12232-129F9	46.90	1.66	5.19	3.32	2.08	1.45	0.21	2.49	1.25	1.87
mature adipocyte, donor3	12233-129G1	41.72	0.47	3.56	1.90	0.95	0.95	0.24	0.47	0.95	0.47
mature adipocyte, donor4	12234-129G2	36.06	2.11	2.37	2.90	2.11	0.00	0.00	0.26	1.32	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	11.20	0.71	4.77	2.62	1.19	2.38	0.24	3.10	0.24	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	1.13	12.41	1.13	2.26	0.00	1.13	0.00	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	35.86	2.76	27.03	3.31	2.21	0.00	0.55	5.15	1.10	10.48
medial frontal gyrus, adult, donor10258	10368-105F8	11.12	0.32	17.79	0.00	1.27	0.00	0.00	0.95	0.32	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	5.54	0.43	2.13	0.00	0.43	0.85	0.00	0.85	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	14.68	1.01	13.67	1.69	1.18	0.17	0.34	1.69	0.17	3.04
medial temporal gyrus, adult, donor10252	10156-103A3	36.50	1.49	26.10	1.70	2.76	0.21	0.64	4.03	1.70	9.97
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	7.71	0.00	3.85	0.00	0.00	0.00	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.82	0.00	3.23	0.72	0.36	0.00	0.36	1.44	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	12.98	1.30	27.91	0.65	0.65	0.00	0.65	1.95	2.60	8.44
medulla oblongata, adult, donor10252	10155-103A2	45.36	1.08	38.39	2.63	2.48	0.46	0.46	7.89	0.77	7.12
medulla oblongata, adult, pool1	10038-101F2	43.34	2.12	36.81	2.12	1.22	0.24	0.49	6.53	0.57	6.37
medulla oblongata, newborn, donor10223	10361-105F1	34.72	2.43	8.68	2.08	2.08	0.69	1.04	3.12	0.00	6.60
medulloblastoma cell line:D283 Med	10838-111E1	5.09	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	40.96	5.26	0.00	4.40	1.96	2.93	1.83	0.00	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	21.42	1.29	0.00	1.72	1.87	0.29	0.86	0.14	1.01	0.00
melanoma cell line:G-361	10465-106H6	0.00	0.00	7.33	0.00	0.00	0.00	0.00	2.71	0.00	1.09
meningioma cell line:HKBMM	10691-109F7	31.84	3.44	0.00	0.72	2.35	5.61	0.90	0.00	0.90	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	28.20	0.00	0.00	3.52	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	14.26	0.78	0.00	1.81	0.26	0.00	0.26	1.04	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	50.17	18.26	1.07	9.36	3.53	0.92	3.84	0.46	3.68	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	59.62	21.81	3.82	10.00	3.09	0.36	6.54	0.73	3.09	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	32.71	17.39	4.56	3.73	4.14	1.24	0.41	0.00	3.73	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	32.45	8.15	4.35	2.11	1.97	0.56	1.26	0.42	2.25	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	24.84	9.82	12.32	2.89	1.16	0.39	2.50	3.85	1.93	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	8.33	24.29	1.39	2.78	0.00	3.47	3.47	0.69	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.36	5.66	10.81	3.26	0.51	0.51	2.57	1.89	1.37	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.38	14.49	6.21	2.30	2.42	0.81	2.88	0.81	2.19	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	43.11	13.40	1.19	6.50	1.72	0.40	1.72	0.80	2.52	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.68	9.18	0.68	4.59	1.76	1.35	1.89	0.27	2.97	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.00	15.36	0.14	7.54	1.99	0.57	3.56	0.00	1.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.71	3.95	1.98	1.65	2.63	0.00	1.98	0.00	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.00	15.36	0.14	6.64	3.74	1.38	4.70	0.14	3.18	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	39.10	14.66	1.75	5.59	1.40	0.35	4.19	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.91	16.33	1.63	3.06	3.06	0.82	4.29	0.20	2.25	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.12	6.47	2.52	1.44	2.52	1.08	1.80	0.36	2.16	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.04	16.97	0.83	4.34	5.90	1.86	3.21	0.00	3.52	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.17	8.89	0.91	2.74	1.60	0.23	2.28	0.00	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.47	18.04	0.00	2.10	3.36	0.42	3.36	0.00	3.78	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	25.11	7.77	0.15	2.39	1.49	0.45	2.24	0.00	2.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.08	16.46	0.53	8.58	3.76	2.10	2.80	0.00	2.89	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.98	11.78	2.95	7.00	1.10	0.37	2.21	0.00	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.34	12.02	0.86	2.29	2.86	1.43	2.00	0.29	1.43	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.31	5.47	0.42	6.74	3.79	0.00	2.95	0.42	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	46.12	7.76	2.28	7.76	3.20	0.46	0.91	0.46	1.83	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	36.32	7.67	1.28	6.65	2.56	1.02	0.51	0.51	1.53	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	46.59	6.28	1.57	6.81	3.14	1.05	2.62	0.79	1.31	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	45.90	8.63	0.31	6.78	1.54	0.62	2.46	1.54	1.85	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	34.60	6.59	0.47	5.88	3.06	1.18	1.41	1.88	1.41	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	47.38	10.15	1.35	7.11	2.71	1.02	2.71	0.68	2.71	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	54.23	10.61	2.75	6.68	1.96	0.79	1.18	0.39	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.85	7.41	2.78	5.56	1.85	0.46	1.85	1.39	1.39	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	48.30	0.00	48.30	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	50.76	8.36	3.46	8.08	2.02	0.87	2.60	2.88	2.60	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	49.53	7.14	3.12	6.02	2.90	1.78	2.01	1.34	2.23	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	47.35	8.65	1.68	6.49	1.92	0.96	2.88	1.68	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	42.53	8.80	2.20	8.80	2.93	0.00	0.73	0.00	2.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	48.33	8.73	1.68	7.72	3.36	1.01	1.01	2.01	2.35	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	35.62	6.55	1.64	2.87	3.28	0.82	2.46	2.05	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.67	7.73	1.29	3.87	3.01	0.00	3.01	0.43	1.72	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	13.67	0.00	2.73	5.47	0.00	2.73	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	44.17	6.50	1.95	6.82	1.95	0.32	2.60	0.32	0.97	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	7.27	0.00	7.27	2.91	0.00	1.45	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	50.64	12.26	5.86	7.46	2.13	0.53	1.60	1.07	1.60	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	54.79	5.72	2.45	5.72	0.82	0.00	3.27	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	53.64	9.33	3.11	4.66	4.28	0.78	1.55	1.94	3.89	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	4.20	4.20	2.10	2.10	0.00	6.30	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	32.78	5.96	1.99	2.98	3.97	0.00	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	9.53	0.00	0.00	4.77	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	48.03	5.93	0.59	4.74	2.96	2.37	0.59	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	52.39	7.31	1.22	4.87	2.44	3.66	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	38.64	5.70	1.27	4.43	2.53	0.00	0.63	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.04	4.14	1.72	4.14	1.72	0.00	1.03	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	51.58	4.30	2.15	0.00	0.00	0.00	0.00	0.00	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	7.98	3.99	0.00	3.99	0.00	3.99	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	0.00	6.89	0.00	0.00	3.44	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	36.26	4.89	1.22	4.07	0.00	0.00	1.63	0.41	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	46.08	3.18	1.59	5.56	0.79	0.00	0.00	1.59	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	33.60	3.54	1.77	2.36	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	37.09	5.92	1.87	2.81	0.31	0.00	1.56	0.62	1.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	6.68	0.00	9.36	0.00	0.00	0.00	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	2.37	4.73	1.18	1.18	0.00	0.00	1.18	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	12.84	2.57	2.57	0.00	0.00	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	37.17	2.07	2.07	3.44	0.00	0.00	1.38	1.38	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	39.09	5.44	0.99	6.93	1.48	0.49	1.98	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	33.65	3.36	1.12	4.49	1.12	0.00	0.00	1.12	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	5.09	0.64	3.18	0.00	0.00	0.64	1.91	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.40	3.63	1.61	5.24	0.81	0.00	0.40	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	2.18	4.36	2.18	0.00	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	0.00	2.53	0.00	1.27	0.00	0.00	3.80	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	32.17	1.82	4.86	9.71	0.61	0.00	0.00	0.61	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	0.00	9.04	4.52	0.00	0.00	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	38.71	3.29	5.77	3.29	0.00	0.00	0.00	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.79	4.37	3.97	4.37	0.20	0.00	3.77	1.59	0.99	1.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	32.77	6.49	7.46	4.87	0.65	0.00	2.27	1.30	0.32	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	39.73	4.07	8.15	1.02	0.00	0.00	2.04	2.04	1.02	7.13
mesodermal tumor cell line:HIRS-BM	10696-109G3	75.82	21.66	0.00	14.70	3.87	0.77	3.87	0.00	2.32	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	92.37	5.91	0.00	13.47	7.09	10.87	0.94	0.00	4.25	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	31.51	6.72	0.46	4.63	2.78	4.17	1.16	0.23	2.78	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	12.82	0.00	17.09	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.45	3.29	0.00	1.03	0.72	0.10	0.82	0.00	0.31	0.00
mesothelioma cell line:Mero-25	10850-111F4	42.89	2.72	0.23	3.63	7.26	7.04	1.59	0.00	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	36.67	6.36	0.00	4.65	7.33	4.40	0.98	0.00	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	39.64	9.52	0.00	4.65	3.10	4.87	1.55	0.00	2.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	60.97	7.88	0.00	5.26	4.20	4.20	1.84	0.00	1.58	0.00
mesothelioma cell line:Mero-83	10854-111F8	20.26	4.60	0.17	2.38	2.55	2.04	0.17	0.00	0.85	0.00
mesothelioma cell line:Mero-84	10855-111F9	45.25	3.54	0.51	7.33	5.06	3.29	0.25	0.00	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	46.17	5.80	0.00	5.18	5.38	5.80	2.90	0.00	0.83	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	42.24	9.61	0.99	3.98	4.97	2.48	1.49	0.00	1.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	34.93	10.50	1.81	3.62	8.14	4.89	1.63	0.00	1.81	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	20.67	4.44	1.20	2.05	3.25	3.59	1.20	0.34	1.37	0.00
mesothelioma cell line:NCI-H28	10845-111E8	18.58	2.04	0.00	1.53	6.11	4.33	0.51	0.00	0.51	0.00
mesothelioma cell line:No36	10857-111G2	13.70	2.61	1.96	2.61	4.57	4.24	0.00	0.65	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	26.82	6.50	0.00	2.71	4.34	3.52	1.35	0.00	1.63	0.00
migratory langerhans cells, donor1	11901-125F2	7.10	0.58	0.77	0.19	0.19	0.96	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	10.38	0.12	0.37	0.12	0.98	0.73	0.12	0.00	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	10.23	0.90	3.41	0.54	0.00	0.18	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	19.59	0.33	0.00	1.31	1.63	1.96	0.00	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.46	5.51	0.00	4.03	4.03	0.42	1.06	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	13.13	0.92	0.23	1.61	1.61	5.99	0.46	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	51.37	13.12	0.37	5.17	1.85	0.18	5.17	0.00	1.85	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	78.63	1.52	0.00	8.12	3.55	2.54	0.51	0.51	3.55	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.19	6.86	7.06	1.57	1.37	1.37	1.57	1.37	0.98	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	25.52	1.56	0.22	1.45	1.34	9.92	0.56	0.00	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.90	2.13	0.07	1.18	0.59	8.24	0.88	0.00	0.29	0.07
nasal epithelial cells, donor2	12227-129F4	27.05	9.38	0.00	2.76	2.21	5.52	1.66	0.00	3.31	0.00
neuroblastoma cell line:CHP-134	10508-107D4	47.16	0.69	0.00	0.69	0.23	0.46	0.00	1.84	0.00	0.46
neuroblastoma cell line:NB-1	10539-107G8	14.97	0.56	0.00	0.75	0.37	0.00	0.19	0.00	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	23.41	1.27	0.00	0.42	0.42	0.21	0.21	0.00	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	50.13	0.56	0.37	0.19	0.56	0.00	0.19	0.19	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	79.71	0.47	0.24	3.08	0.24	0.00	0.24	0.95	0.71	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.26	0.16	0.00	0.95	0.00	0.00	0.00	0.00	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	20.53	0.40	0.00	2.01	0.20	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	247.95	2.54	0.00	11.44	0.00	0.00	0.64	0.00	2.54	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	75.86	21.56	1.60	9.05	6.39	0.80	4.79	1.33	2.13	2.93
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	11.50	0.51	0.00	1.86	0.85	0.17	0.34	3.55	0.34	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1.60	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	56.11	18.27	0.64	7.37	2.56	0.64	8.34	0.32	3.53	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	53.34	10.25	0.26	4.47	3.68	0.53	3.15	0.00	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	23.81	1.97	19.22	1.69	1.41	0.19	0.47	4.31	0.84	3.94
occipital cortex - adult, donor10196	10172-103C1	28.85	4.12	10.30	0.00	2.06	0.00	0.00	0.00	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	52.60	3.22	33.81	2.68	2.68	0.81	0.27	6.44	1.07	10.47
occipital cortex, newborn, donor10223	10355-105E4	9.46	0.36	5.10	0.36	0.00	0.36	0.36	0.36	0.00	2.18
occipital lobe, adult, donor1	10076-102A4	25.98	1.84	12.86	0.79	2.10	0.26	0.52	2.89	0.52	1.31
occipital lobe, fetal, donor1	10073-102A1	28.75	0.86	1.29	2.15	0.43	0.00	0.43	0.43	0.00	0.43
occipital pole, adult, pool1	10036-101E9	41.23	4.02	17.19	1.81	6.62	0.47	1.97	3.31	2.05	2.52
olfactory region, adult	10195-103E6	17.39	0.96	22.93	1.15	1.53	0.38	0.19	4.01	0.38	5.73
optic nerve, donor1	10277-104E7	40.02	0.00	52.03	4.00	0.00	0.00	2.00	2.00	0.00	16.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.89	2.96	0.00	1.94	2.73	10.59	1.48	0.00	0.57	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	36.27	1.92	0.00	3.16	1.92	1.37	0.27	0.00	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.80	1.19	0.00	0.17	0.85	0.34	0.00	0.00	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.84	5.43	0.35	3.23	9.47	14.32	1.16	0.00	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	71.14	6.17	0.00	5.59	6.76	3.82	2.35	1.47	1.76	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	0.93	0.93	4.67	1.87	0.00	0.00	0.93	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	31.60	5.09	1.48	5.94	0.21	0.00	1.70	8.06	1.06	3.39
ovary, adult, pool1	10020-101D2	88.66	5.50	14.06	7.25	5.77	0.96	2.45	8.82	1.66	5.07
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	1.47	0.18	0.18	0.00	0.18	0.00	0.00	0.00	0.18	0.00
pancreas, adult, donor1	10049-101G4	14.11	0.94	4.70	3.76	7.53	6.58	0.00	2.82	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	30.75	0.28	0.00	4.47	0.56	0.28	0.28	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	23.85	4.09	0.00	2.04	2.90	1.87	0.85	0.00	1.36	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.38	1.32	0.00	1.66	0.99	5.30	0.83	0.17	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	24.25	1.56	16.11	0.92	3.11	0.09	0.92	3.29	0.82	3.29
parietal cortex, adult, donor10258	10373-105G4	9.54	1.47	13.95	0.00	2.94	1.47	0.73	1.47	0.00	3.67
parietal lobe - adult, donor10196	10171-103B9	9.40	1.88	14.11	1.88	0.00	0.00	0.00	1.88	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	30.21	1.43	29.36	2.28	1.14	0.00	0.29	4.56	0.29	8.27
parietal lobe, adult, pool1	10034-101E7	22.82	1.06	18.06	1.15	1.50	0.09	0.35	3.35	0.44	3.08
parietal lobe, fetal, donor1	10072-101I9	44.61	1.94	0.97	1.94	2.91	0.00	0.00	1.94	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	10.84	0.75	4.11	1.50	0.37	0.00	0.00	0.75	0.00	1.87
parotid gland, adult	10199-103F1	35.15	6.78	9.25	3.70	0.62	6.17	1.23	0.62	0.62	0.62
penis, adult	10200-103F2	63.38	1.07	33.30	3.76	0.54	2.69	1.07	16.65	1.07	16.65
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	102.82	0.37	1.30	2.79	1.12	1.12	0.00	0.37	0.93	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	25.50	3.79	0.15	3.93	0.44	2.48	0.87	0.15	1.46	0.00
pineal gland - adult, donor10196	10179-103C8	29.03	0.65	9.68	0.65	1.29	1.94	0.00	2.58	0.65	1.94
pineal gland, adult, donor10252	10160-103A7	38.49	2.96	14.21	1.78	2.37	4.74	0.59	1.18	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	23.83	1.88	16.30	0.63	2.51	8.15	1.25	0.63	0.00	1.88
pituitary gland - adult, donor10196	10180-103C9	50.59	7.08	4.05	3.04	9.11	15.18	1.01	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	58.89	4.69	11.47	2.61	3.13	6.78	2.61	2.08	1.56	3.13
pituitary gland, adult, donor10258	10378-105G9	26.39	0.85	9.36	0.00	1.70	10.21	1.70	2.55	0.85	0.00
placenta, adult, pool1	10021-101D3	29.67	5.38	10.32	3.98	2.04	0.65	1.08	9.14	1.61	6.02
plasma cell leukemia cell line:ARH-77	10840-111E3	2.52	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.79	5.60	0.00	1.71	3.74	1.71	2.18	0.00	2.18	0.00
pons, adult, pool1	10033-101E6	26.59	1.55	26.94	0.95	2.50	0.60	0.17	3.53	0.60	4.56
postcentral gyrus, adult, pool1	10032-101E5	28.42	2.18	21.18	2.18	2.70	0.26	0.87	2.70	1.05	4.10
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	39.77	4.08	0.29	4.08	4.37	13.26	1.02	0.15	1.46	0.00
prostate cancer cell line:PC-3	10439-106E7	29.77	5.26	0.36	7.62	2.54	5.45	1.27	0.00	1.09	0.00
prostate, adult, pool1	10022-101D4	59.49	3.63	19.68	4.53	2.99	3.45	1.63	8.98	1.18	6.98
putamen, adult, donor10196	10176-103C5	33.52	0.71	10.62	1.18	0.94	0.24	0.00	3.54	1.18	3.78
putamen, adult, donor10252	10152-102I8	9.80	1.96	17.65	0.00	0.00	0.00	0.00	0.00	0.00	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	0.00	13.11	1.09	1.09	0.00	0.00	1.09	0.00	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	18.60	0.00	15.22	1.93	1.45	0.24	0.24	0.72	0.97	2.90
putamen, newborn, donor10223	10365-105F5	16.49	0.75	3.75	0.75	0.00	0.00	0.00	0.75	0.75	6.00
rectal cancer cell line:TT1TKB	10469-106I1	19.78	3.20	1.16	3.20	2.04	0.29	1.16	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	143.27	8.35	8.35	18.08	19.47	0.00	1.39	13.91	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.66	9.75	0.85	1.70	6.36	6.15	1.06	0.42	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.98	0.00	1.24	0.83	0.83	2.07	0.41	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	69.18	7.06	70.28	4.67	3.18	1.59	3.78	11.23	1.69	6.56
retinoblastoma cell line:Y79	10475-106I7	32.99	1.04	0.00	2.34	0.52	0.00	0.00	0.00	1.30	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	29.88	2.09	0.00	2.95	1.23	0.12	0.37	0.00	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	61.58	2.25	0.00	5.34	1.12	0.56	0.84	2.81	0.56	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	103.83	14.40	3.03	10.61	1.52	0.76	4.55	4.55	0.76	3.03
salivary acinar cells, donor1	11771-123I7	34.96	4.37	0.00	2.43	0.81	3.88	0.97	0.00	0.97	0.00
salivary acinar cells, donor2	11772-123I8	43.10	6.47	0.55	2.34	0.96	3.44	2.48	2.62	1.10	2.20
salivary acinar cells, donor3	11773-123I9	66.87	5.30	1.99	4.63	0.66	8.61	1.32	3.31	1.32	1.99
salivary gland, adult, pool1	10093-102C3	37.75	5.15	5.15	0.57	1.72	16.59	2.29	1.72	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.86	4.22	1.35	2.95	5.06	2.70	1.43	0.25	1.10	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.10	4.00	0.94	3.17	3.17	3.64	1.41	0.00	0.35	0.00
seminal vesicle, adult	10201-103F3	40.74	1.59	17.46	1.59	2.65	5.82	0.53	6.35	0.53	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	13.36	4.13	0.00	0.97	0.97	4.37	1.21	0.00	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.23	3.27	0.00	3.27	2.26	2.26	0.50	0.00	2.77	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	39.14	11.04	0.00	3.01	5.02	3.01	2.01	0.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.58	5.37	2.01	3.49	26.33	20.69	4.30	1.34	0.40	1.34
signet ring carcinoma cell line:Kato III	10436-106E4	21.00	2.10	3.98	1.99	1.77	5.97	1.22	0.33	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.42	0.52	1.81	0.26	2.97	3.87	0.00	0.26	0.00	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	19.86	0.71	30.50	2.13	0.71	0.00	0.00	12.77	0.00	2.13
skeletal muscle, adult, pool1	10023-101D5	17.99	1.20	28.31	0.96	1.08	0.96	0.72	13.55	0.36	6.36
skeletal muscle, fetal, donor1	10066-101I3	69.35	6.03	12.06	10.05	0.00	0.00	3.02	13.07	4.02	10.05
skin, adult, donor1	10074-102A2	61.07	0.00	33.93	0.00	0.00	6.79	0.00	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	61.86	10.73	11.99	3.79	0.63	2.52	1.26	6.94	2.52	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	54.03	6.00	0.67	6.67	5.00	6.34	2.00	1.33	3.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	89.52	7.56	1.89	12.29	7.56	4.41	3.15	1.26	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	13.30	0.77	0.00	3.47	0.58	0.19	0.00	0.00	0.77	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	52.42	2.14	0.66	2.14	2.14	4.45	0.82	0.00	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	38.60	0.64	0.00	7.08	1.93	0.00	0.00	0.16	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	12.64	1.96	1.74	0.44	1.53	4.36	0.00	0.00	0.44	0.00
small intestine, adult, pool1	10024-101D6	26.16	2.39	6.21	2.03	53.87	26.52	0.60	3.58	0.60	2.51
small intestine, fetal, donor1	10064-101I1	46.44	7.86	1.72	4.67	22.36	1.97	2.70	2.21	1.97	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	12.82	1.03	6.67	0.00	2.56	11.28	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	62.80	2.33	25.59	1.81	1.81	0.52	0.26	8.27	1.55	6.20
somatostatinoma cell line:QGP-1	10781-110G7	10.45	0.54	0.27	1.07	0.80	5.90	0.00	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	31.66	1.38	42.67	2.29	0.46	0.00	0.23	3.44	0.00	4.59
spinal cord, adult, donor10252	10159-103A6	44.95	1.58	49.68	1.97	0.39	0.39	0.00	3.55	0.39	4.73
spinal cord, adult, donor10258	10369-105F9	17.29	0.69	25.60	1.38	0.00	0.69	0.00	0.69	0.00	4.84
spinal cord, fetal, donor1	10056-101H2	77.45	5.49	9.76	3.66	2.44	0.00	1.22	3.05	3.66	3.66
spinal cord, newborn, donor10223	10359-105E8	25.26	1.38	2.76	1.38	0.92	0.00	0.92	1.84	0.46	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	69.60	15.38	0.15	10.45	7.62	2.69	5.23	0.15	3.29	0.30
spleen, adult, pool1	10025-101D7	24.12	3.52	14.43	3.30	0.99	3.08	1.43	1.21	1.32	0.22
spleen, fetal, pool1	10044-101F8	46.72	10.09	23.68	9.61	1.83	0.95	3.50	4.29	1.91	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.99	2.47	0.00	1.14	0.76	3.42	0.76	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	26.56	2.10	1.75	3.84	0.35	3.15	0.70	1.40	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.20	0.78	0.00	0.78	1.95	5.47	1.95	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.82	0.90	0.00	0.34	0.79	4.05	0.56	0.00	0.23	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.57	3.39	0.00	2.12	0.85	3.39	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	35.11	5.50	0.00	4.23	1.69	1.69	1.27	0.00	0.85	0.42
stomach, fetal, donor1	10062-101H8	85.44	4.27	12.82	6.41	2.14	5.34	2.14	8.54	2.14	7.48
submaxillary gland, adult	10202-103F4	41.59	2.28	5.13	0.57	1.71	8.55	1.71	2.85	0.57	1.71
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	54.27	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	27.42	1.04	36.76	2.70	0.62	0.00	0.00	4.98	0.21	5.61
substantia nigra, adult, donor10258	10371-105G2	13.97	0.00	22.76	0.52	0.52	0.00	0.52	0.00	0.00	8.28
substantia nigra, newborn, donor10223	10358-105E7	19.78	2.83	12.01	0.71	0.00	0.00	1.41	4.95	0.00	9.19
synovial sarcoma cell line:HS-SY-II	10441-106E9	44.94	1.38	0.00	3.21	1.15	0.00	0.23	0.23	1.83	0.00
temporal lobe, adult, pool1	10031-101E4	22.55	0.85	20.26	2.03	1.44	0.17	0.76	3.73	0.17	4.24
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.05	1.42	1.42	2.85	2.14	0.00	0.00	1.42	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	30.33	0.00	3.52	1.76	3.08	0.44	0.00	0.88	0.44	0.44
tenocyte, donor1	11763-123H8	74.01	21.30	3.14	9.08	3.84	1.05	7.33	1.40	5.59	0.35
tenocyte, donor2	11765-123I1	55.70	12.21	15.64	4.96	2.29	0.38	2.29	4.58	1.53	6.10
tenocyte, donor3	11768-123I4	58.57	18.90	4.82	7.78	3.34	1.48	2.97	5.93	5.56	5.19
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	24.47	0.00	0.17	2.21	0.51	0.17	0.00	0.00	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	48.71	2.62	0.31	6.32	4.93	0.00	0.62	3.08	0.31	3.55
teratocarcinoma cell line:PA-1	10807-111A6	63.54	0.93	0.15	3.56	3.87	0.15	0.46	0.00	0.62	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.20	0.76	0.76	1.27	1.90	0.00	0.25	0.00	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.32	0.38	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	27.48	2.07	7.85	1.53	0.22	0.00	0.00	0.33	0.33	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	24.43	1.63	0.00	0.33	0.98	0.00	0.33	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	38.98	3.22	28.67	1.93	1.72	1.50	2.15	12.46	0.75	7.19
testis, adult, pool2	10096-102C6	32.93	2.71	12.18	1.80	2.71	0.90	1.35	6.32	1.35	3.61
thalamus - adult, donor10196	10168-103B6	11.04	0.00	29.81	0.00	0.00	0.00	0.00	4.42	0.00	1.10
thalamus, adult, donor10252	10154-103A1	32.35	1.09	34.23	1.88	0.94	0.00	0.31	4.84	0.31	7.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	0.00	35.41	0.00	1.54	0.00	0.00	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.49	1.32	25.53	1.15	0.49	0.16	0.00	1.98	0.16	5.60
thalamus, newborn, donor10223	10366-105F6	16.68	0.00	6.33	0.58	8.63	0.58	0.58	2.88	1.15	3.45
throat, adult	10209-103G2	32.96	3.99	20.72	4.74	0.75	4.99	1.00	8.99	1.25	4.49
throat, fetal, donor1	10061-101H7	66.73	7.31	4.88	4.88	1.22	4.57	1.22	5.79	2.13	5.79
thymic carcinoma cell line:Ty-82	10803-111A2	72.34	8.35	0.20	11.13	4.57	0.40	0.99	0.00	2.38	0.00
thymus, adult, pool1	10027-101D9	6.96	0.30	2.29	0.20	0.20	0.20	0.10	0.50	0.20	0.10
thymus, fetal, pool1	10043-101F7	9.87	1.77	4.68	1.56	0.21	1.04	0.21	1.66	0.31	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.01	3.46	0.13	4.12	6.38	3.72	1.60	0.00	0.66	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	37.02	5.73	0.98	3.21	1.82	1.40	1.96	0.28	0.84	0.00
thyroid, adult, pool1	10028-101E1	58.41	2.43	7.28	4.48	3.17	13.25	0.65	4.57	0.56	2.89
thyroid, fetal, donor1	10060-101H6	48.51	5.27	5.27	6.33	2.90	3.69	1.05	3.95	2.11	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	70.83	0.00	61.59	3.08	3.08	0.00	0.00	36.96	0.00	24.64
tongue, adult	10203-103F5	25.35	3.02	20.70	3.49	0.47	5.81	0.00	19.77	0.93	10.23
tongue, fetal, donor1	10059-101H5	28.37	3.55	6.70	4.73	0.79	3.55	1.97	16.95	0.79	5.52
tonsil, adult, pool1	10047-101G2	28.45	2.50	7.81	1.70	0.60	7.71	0.70	3.61	1.00	1.20
trachea, adult, pool1	10029-101E2	32.80	4.34	12.76	3.76	2.04	6.79	1.15	7.03	0.57	5.24
trachea, fetal, donor1	10058-101H4	54.24	6.92	6.92	5.77	0.77	1.15	4.23	9.62	3.46	5.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	65.54	18.42	0.00	7.09	6.73	1.06	7.09	0.00	3.54	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	15.91	2.53	0.30	2.63	2.33	5.37	0.41	0.00	1.01	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	41.68	9.09	1.88	4.86	2.35	3.45	3.13	0.00	1.57	0.00
tridermal teratoma cell line:HGRT	10694-109G1	123.66	3.81	3.81	11.42	5.71	1.90	1.90	1.90	3.81	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	27.68	1.95	0.00	2.29	3.22	2.79	0.34	0.00	1.02	0.00
umbilical cord, fetal, donor1	10057-101H3	58.42	6.26	4.17	6.26	4.17	0.00	0.00	6.26	0.00	10.43
uterus, adult, pool1	10100-102D1	81.22	7.17	33.10	3.92	4.95	2.73	1.19	14.84	4.10	13.14
uterus, fetal, donor1	10055-101H1	75.25	11.77	6.14	9.21	7.68	2.56	4.10	6.14	4.10	5.12
vagina, adult	10204-103F6	54.93	2.58	21.32	6.46	0.00	2.58	0.00	20.03	1.29	9.05
vein, adult	10191-103E2	49.98	1.53	27.62	3.51	0.66	0.66	0.88	8.11	0.44	3.95
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.60	0.00	1.07	0.00	0.00	0.00	0.00	0.27	0.00	0.00